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Summary 
 
West Nile virus (WNV) and Rift Valley Fever virus (RVFV) are two emerging arboviruses 
that have never been reported in Lebanon. They can be transmitted by Culex pipiens mosquito 
species including two biotypes: pipiens and molestus. During this project, we assessed the 
circulation of WNV among mosquitoes, human, horse and chicken populations in Lebanon. 
Moreover, we evaluated, under experimental conditions, the capacity of local Cx. pipiens 
biotypes to transmit both viruses. 
Adult mosquitoes were collected, identified and tested to detect WNV RNA. Besides, human, 
horse and chicken blood samples were collected and screened for WNV antibodies using an in-
house ELISA and then confirmed by neutralization assay. Moreover, local Cx. pipiens specimens 
were experimentally infected with WNV lineage 1 or RVFV Clone 13 strain. The viral infection, 
dissemination and transmission were then estimated at different days post infection.The vector 
competence was compared between Cx. pipiens biotypes. 
Entomological results revealed that 87.2% of collected adult mosquitoes were Cx. pipiens. 
Screened mosquitoes were negative for WNV. Seroprevalence rates were 1.01% and 1.98% 
among humans and horses respectively. Besides, local Cx. pipiens were highly competent for 
WNV transmission and to a lesser extent to RVFV. The molestus biotype was able to transmit 
WNV earlier than pipiens biotype. 
The present study provides new evidence of a low circulation of WNV among human and 
horses in Lebanon. Cx. pipiens is the suspected vector and is experimentally competent to ensure 
transmission. Therefore, there is a need to establish surveillance program to predict and prevent 
potential outbreaks. 
 
Keywords: West Nile Virus, Rift Valley Fever Virus, Culex pipiens, Lebanon, Vector 
competence, Seroprevalence. 
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Résumé 
 
Le Virus du Nil Occidental (VNO) et le Virus de la Fièvre de la Vallée du Rift (VFVR) sont 
deux arbovirus transmis par le moustique Culex pipiens comprenant deux biotypes: pipiens et 
molestus. Au cours de ce projet, nous avons évalué la circulation du VNO au Liban dans des 
populations de moustiques, des humains, des chevaux et des poulets. Nous avons aussi évalué la 
compétence vectorielle des populations locales de Cx. pipiens à transmettre le VNO et le VFVR. 
Des moustiques ont été récoltés et testés pour la présence d’un gène spécifique du VNO. En 
plus, des sérums humains, de chevaux et de poulets ont été analysés pour rechercher des 
anticorps spécifiques par ELISA puis confirmés par neutralisation. En outre, des spécimens de 
Cx. pipiens ont été infectés avec la lignée 1 du VNO ou la souche de VFVR Clone 13. Ensuite, 
les taux d’infection, de dissémination et de transmission ont été déterminés à différents jours 
après infection des moustiques. La compétence vectorielle a été comparée entre les différents 
biotypes. 
Les résultats entomologiques ont révélé que Cx. pipiens est dominant (87.2%). Tous les 
moustiques analysés étaient négatifs pour le VNO. Les taux de séroprévalence étaient de 1.01% 
et 1.98% parmi les humains et les chevaux respectivement. De plus, Cx. pipiens s’est révélé bien 
plus compétent pour transmettre le VNO que le VFVR. Le biotype molestus est capable de 
transmettre le VNO plus tôt que celui de pipiens.  
Cette étude présente des preuves sur une faible circulation du VNO au Liban. Cx. pipiens 
s’est révélé compétent pour assurer cette transmission. Ainsi, il est essentiel d'établir des 
programmes de surveillance pour prévenir les éventuelles épidémies. 
 
Mots Clés: Virus du Nil Occidental, Virus de la fièvre de la Vallée du Rift, Culex pipiens, Liban, 
Compétence Vectorielle, Séroprévalence.  
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General Introduction 
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West Nile virus (WNV) is a mosquito-borne zoonotic agent member of the Flavivirus genus 
(Flaviviridae family). It was first isolated in Uganda in 1937 (Smithburn et al., 1940). Usually, 
only 20% of infected individuals develop symptoms and less than 1% develops serious and 
potentially fatal neurological illnesses such as meningitis and encephalitis. Birds are considered 
the main reservoir  and migratory birds are involved in the introduction of the virus into new 
regions (Andreadis, 2012). WNV infections have been reported in many tropical and temperate 
countries in Africa, Europe, Asia and America (CDC, 2017; Failloux et al., 2017). The East 
Mediterranean region (EMR) has long been considered endemic for WNV. Locally acquired 
cases have been recently reported in Israel (Paz and Semenza, 2013), Greece (Papa, 2017), and 
Turkey (Kalaycioglu et al., 2012). In addition, evidence of WNV circulation has been reported 
from Jordan (Batieha et al., 2000) and Egypt (Soliman et al., 2010). It is worth noting that the 
introduction of WNV into the United States in 1999, which constitutes a turning point in WNV 
epidemiology, is thought to have originated from the EMR (Israel) following introduction from 
Africa (Giladi et al., 2001; Lanciotti et al., 1999). 
WNV is mainly transmitted by mosquitoes of the Culex genus especially those belonging to 
the Culex pipiens complex (Turell, 2012). In the Mediterranean basin, this complex is mainly 
represented by Cx. pipiens s.s. under its two biotypes: Cx. pipiens pipiens and Cx. pipiens 
molestus. 
To date, no WNV cases have been reported from Lebanon. However, the country is 
considered at risk for WNV outbreak. Not only it is geographically part of an endemic region, 
but also Lebanon is located on the flyways of migratory birds. Besides, entomological studies 
conducted in 1999-2001 showed a widespread of Culex pipiens (Knio et al., 2005). Additional 
entomological surveys conducted by our laboratory (Laboratory of Immunology and Vector-
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Borne Diseases, Lebanese University) during the last decade confirmed the spread of this 
mosquito that colonizes urban and rural habitats (unpublished data). 
The abundance of Culex pipens is considered a risk factor for local transmission, not only of 
WNV, but of also other arboviruses. Indeed, this species is a possible vector of Rift Valley Fever 
Virus (RVFV). This virus is of particular interest for Lebanon and the Mediterranean countries. 
It is mainly spread in the Sub-Saharan region in Africa (Himeidan et al., 2014). Recorded 
substantial expansion to areas close to the Mediterranean basin, such as Egypt (Meegan, 1979), 
Mauritania (El Mamy et al., 2011), Senegal and even the Arabian Peninsula (Saudi Arabia and 
Yemen (Ahmad, 2000)) should be considered as a health threat for Mediterranean countries, 
including Lebanon. Intensive livestock trade between Lebanon and these countries increases the 
risk of RVFV introduction. 
During this PhD research project, we aimed to assess the circulation of WNV in Lebanon and 
the capacity of local strains of Cx. pipiens to transmit WNV and RVFV under experimental 
conditions. Therefore, our project is divided into two sections: 
The first section covers the epidemiology of WNV in Lebanon and attempts to provide 
evidence of WNV circulation by screening mosquito populations for WNV RNA and by 
detecting WNV specific antibodies among human, horses and chicken populations. 
The second section of this study includes an assessment of the vector competence of local 
populations of Cx. pipiens against both WNV and RVFV. For this, experimental transmission 
assays were conducted in Biosafety Level 3 (BSL3) facilities at the Unit of Arboviruses and 
Insect Vectors (Institut Pasteur, Paris, France). Moreover, the difference of vector competence 
between both Cx. pipiens biotypes was investigated. 
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This manuscript is divided in two parts Litterature Review and Empirical Studies. The first 
part is composed of four chapters. Chapter 1 is an overview of the mosquito vector Culex 
pipiens, its biology and medical importance. In this chapter, we present classical and advanced 
methods to control mosquito populations and discuss the related challenges. Chapters 2 and 3 
describe West Nile Virus and Rift Valley Fever Virus, their epidemiology, diagnosis and 
pathogenesis. Chapter 4 discusses the knowledge related to the vector-virus interactions. Chapter 
5 specifies the study objectives of the present research project. The second part presents the work 
performed during this thesis project. It is composed of three chapters. In chapter 6, we assess the 
circulation of WNV in Lebanon by conducting entomological and seroprevalence surveys. In 
chapter 7, we assess the vector competence of Lebanese strains of Culex pipiens against West 
Nile Virus and Rift Valley Fever Virus. Chapter 8 presents the general discussion and conclusion 
related to the epidemiology of WNV in the country.  
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Chapter 1 
Overview on Culex pipiens mosquito vector 
 
Culex pipiens complex mosquitoes belong to the Culicidae family, Culicinae subfamily. 
They have a global distribution and are considered vectors of several medically important 
arboviruses such as West Nile Virus (WNV) and Rift Valley Fever Virus (RVFV). 
 
1. Classification 
There are more than 3500 species of mosquitoes, all belonging to the Culicidae family 
(Service, 2007) that is divided into three subfamilies: Toxorhynchitinae, Anophelinae 
(anopheline) and Culicinae (culicine). The subfamily Culicinae comprises more than 40 genera 
(Service, 2007) among which Culex and Aedes include an important number of medically 
important species. Culex mosquitoes are widespread in almost all the continents with more than a 
thousand species (Becker et al., 2010). Within this genus, we  recognize Culex pipiens which is 
considered a complex or assemblage of medically important species (Harbach, 2012). 
Culex pipiens mosquitoes are found worldwide, but they are absent from the extreme 
northern parts of the temperate zones. The taxonomy of the Cx. pipiens complex is controversial 
and has constantly changed. Based on Harbach’s last revision (Harbach, 2012), the Cx. pipiens 
complex includes Cx. pipiens s.s., Cx. quinquefasciatus and the form pallens and possibly, Cx. 
australicus (Harbach, 2012; Harbach et al., 1985; Turell, 2012). The females of the complex 
members cannot be distinguished morphologically. Cx. pipiens s.s .includes two biotypes or 
subspecies: Cx. pipiens pipiens and Cx. pipiens molestus (Fonseca et al., 2004; Harbach, 2012). 
Harbach (2012) considered that the nominal forms pipiens and quinquefasciatus are 
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phylogenetically distinct species; they do not interbreed in the region where they co-exist. They 
are distinct outside the areas of introgression where the form pallens is described. According to 
this author, the pallens form does not meet the criteria for subspecies status. Harbach did not 
conclude on the status of Culex australicus and considered that this taxon “may or may not be a 
member of the pipiens assemblage” (Harbach, 2012). 
 
2. Geographic distribution 
A worldwide general distribution map of the Culex pipiens complex species was elaborated 
by Farajollahi and collaborators (2011) (Figure 1). Culex pipiens s.s. (including both biotypes 
and their hybrids) is present in European and Asian countries in addition to all Mediterranean 
countries including Lebanon (Farajollahi et al., 2011; Knio et al., 2005). This species has been 
accidentally introduced into temperate zones in North and South America, while only Cx. pipiens 
biotype molestus has been introduced to cities in Japan, Republic of South Korea, and Australia 
(Farajollahi et al., 2011; Fonseca et al., 2004). Cx. quinquefasciatus thrives in tropical and sub-
tropical regions including the African lowlands, Americas, Asia, and Australia as shown in the 
distribution map (Figure 1). A recent study conducted by Shaikevich and collaborators (2016) 
provided the first molecular evidence of the presence of hybrids between Cx. quinquefasciatus 
and Cx. pipiens in coastal regions of Southern Europe and Mediterranean region (Morocco) 
(Shaikevich et al., 2016). In addition, they confirmed the presence of hybrids between pipiens 
and molestus biotypes in the study areas in Europe and around the Mediterranean Sea 
(Shaikevich et al., 2016). 
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Figure 1. Global distribution of Culex pipiens complex mosquitoes (Farajollahi et al., 2011). 
 
3. External morphology of adults 
Adults of Culex pipiens, as any other mosquito, have a body that is divided into three parts: a 
head, thorax and abdomen (Figure 2). The head has a conspicuous forward-projecting proboscis 
and carries a pair of segmented antennae. Mosquitoes can be sexed by examining their antennae: 
individuals with feathery antennae are males while those with only short and rather 
inconspicuous antennal hairs are females. In addition, the palps (below the antennae) of female 
mosquitoes (as female Culicines) are very short while in males they are long. Arising between 
the palps is the single long proboscis which in females contains the piercing mouthparts, thus 
only female mosquitoes can bite. 
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Figure 2. Culex pipiens anatomy diagram (Credit: Callista Images). 
 
The thorax is ornamented with numerous scales that allow the discrimination between 
species. Moreover, the thorax provides an insertion site of three pairs of legs and one pair of 
functional wings. The abdomen of mosquitoes is composed of 10 segments, but only the eight 
are visible. The last two segments are reduced and form the genitalia (Service, 2007). The 
abdomen is usually covered dorsally and ventrally with brown and white scales. The dorsal parts 
of the abdomen are called tergites, they are important criteria for Culex species identification 
(Service, 2007). 
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Culex pipiens s.l. are characterized by the following morphological criteria: 
At the Culex genus level: 
- a scutellum clearly trilobate in thorax (Figure 3.A) 
- absence of both pre-spiracular and post-spiracular setae in thorax 
- sensory organs at the apex of the tarsomere 5 with an empodium and 2 pulvilli 
- a wing characterized by: a fringe of scales in the alula and the apex of the vein 1-A 
localized beyond the mcu/cuA fork (Figure 3.B) 
At the species level: 
- a wing with an entirely dark costal vein (Figure 3.B) 
- entirely dark legs (femur, tibia and tarsomeres of the 3 pairs of legs) 
- basal pale band on their tergites (Figure 3.C) 
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Figure 3. Culex pipiens morphological characteristics: A. Trilobate scutellum. B. Wing characteristics: fringe 
of scales in the alula (left arrow), dark costal vein (right arrow), apex of the vein 1-A (middle red arrow) 
beyond the mcu/cuA fork (blue arrow). C. Pale basal band on tergites (The mosquitoes of the Mediterranean 
Africa, IRD, France, CD-ROM, 1999). 
 
Morphological discrimination between members of the Cx. pipiens complex is very difficult 
and sometimes not possible. Cx. pipiens pipiens and Cx. pipiens molestus can only be 
distinguished using molecular techniques such as Polymerase Chain Reaction (PCR) (Bahnck 
and Fonseca, 2006; Fonseca et al., 2004; Price and Fonseca, 2015). 
 
4. Life cycle and biology of different stages 
Culex pipiens mosquitoes, as all Culex species, go through four separate and distinct stages 
during their life cycle: egg, larva, pupa, and adult (Figure 4). 
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Figure 4. Culex pipiens life cycle (AMCA, 2017). 
 
a. Oviposition and biology of eggs 
Female Culex pipiens mosquitoes lay their eggs on the surface of fresh water or in 
temporarily wet areas like flood plains (Figure 5). They lay up to 300 eggs in one oviposition 
directly on the water surface (Service, 2007). Eggs are usually brown, long and cylindrical of 
1mm or less in length. They are laid upright in several rows on the water surface and held 
together by surface tension to form an egg raft that floats on the water. These eggs cannot 
survive to desiccation and die when dry. Time from egg hatching to larvae stage varies from 2 to 
3 days in the tropical regions, 7 to 14 days in cooler temperate areas (Becker et al., 2010). 
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Figure 5. Female Culex pipiens laying eggs. Photograph by Sean McCann (University of Florida). 
 
b. Larval biology 
Larvae have a well-developed head bearing a pair of antennae and a pair of compound eyes. 
The thorax is roundish and usually has long and conspicuous hairs. The last segment of the 
abdomen differs in shape from the other segments. It ends with two pairs of transparent sausage-
shaped anal papillae, which are concerned with osmoregulation (Becker et al., 2010). Cx. pipiens 
larvae must come to the water surface to breath. Atmospheric air is taken in through a pair of 
spiracles situated at the end of a single tube termed the respiratory siphon. Cx. pipiens larval 
siphon is often long and narrow, possessing always more than one pair of subventral tufts of 
hairs. 
There are four active larval instars. They feed on yeasts, bacteria, protozoans, decaying 
organic matter found in the water. Larval development (time from egg hatching to pupation) 
depends on areas, temperatures and species, it can be 5 to 7 days, but may also last about 7 to 14 
days (Becker et al., 2010). 
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Larval habitats of Culex pipiens mosquitoes, as most Culex species, are ground collections of 
water such as pools, puddles, ditches, borrow pits and rice fields. In urban areas, this species lays 
eggs in man-made container-habitats such as tin cans, water receptacles, bottles and water-
storage tanks with variable amount of organic matter (Service, 2007). 
 
c. Pupae biology 
Cx. pipiens mosquito pupae are aquatic and comma-shaped (Service, 2007). The head and 
thorax are combined to form the cephalothorax, which dorsally possesses a pair of respiratory 
trumpets. Pupae do not feed but spend most of their time resting at the water surface to take air 
(Service, 2007). The pupal development may take 2-3 days in tropical areas, but in cooler 
temperate regions, pupal period can last 9-12 days. At the end of pupal life the skin on the dorsal 
surface of the cephalothorax splits, and the adult mosquito struggles out (Becker et al., 2010). 
 
d. Adult biology and behavior 
Most Cx. pipiens mosquitoes mate shortly after emergence. Sperm from a male enter the 
spermatheca of a female, and this usually serves to fertilize all eggs laid during her lifetime 
(Becker et al., 2010). Female mosquitoes must bite a host and take a blood-meal to obtain the 
necessary nutrients for the development of eggs. This is referred as anautogenous development 
(Service, 2007). However, some Cx. pipiens forms can develop the first batch of eggs without a 
blood-meal, and more rarely, subsequent batches. This process is called autogenous development 
(Service, 2007). The blood-meal digestion depends on temperature and varies from 2 to 3 days in 
hot climates, to 7–14 days in colder areas. After full digestion, the Cx. pipiens female is gravid 
and ready to lay eggs in suitable larval habitats (Service, 2007). Male Cx. pipiens mosquitoes, 
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along with other species, cannot bite but feed on the nectar of flowers and other natural sugar 
secretions, along with females in order to obtain energy for flying. 
Adult Cx. pipiens mosquitoes mainly disperse only a few hundred meters from their 
emergence sites. In Japan, a mark–release–recapture of Culex pipiens pallens showed that the 
maximum flight distance was estimated as 1217m with a mean distance flight that did not exceed 
517m (Tsuda et al., 2008). In some cases, this distance is longer when the mosquitoes are wind-
assisted. In tropical areas, adult female mosquitoes live 1–2 weeks in average whereas in 
temperate countries, adult life may be extended to 3–4 weeks (Becker et al., 2010). Species that 
hibernate live much longer: for instance in Europe, some fertilized female Culex pipiens survive 
in hibernation from season to another (Becker et al., 2010). Adult male mosquitoes have a 
shorter life span than females. 
Cx. pipiens subspecies differ significantly in physiology, behavior and ecology (Table 1). Cx. 
pipiens biotype pipiens is mainly present in temperate areas, ornithophilic (bird biting host 
preference), anautogenous and eurygamous (mating in outdoor swarms only) whereas the 
biotype molestus, thrives in sewers in sub-tropical regions, is mammophilic (prefers biting 
mammals including humans), autogenous and stenogamous (ability to mate in a confined space) 
(Fonseca et al., 2004; Harbach, 2012). The hybrids of these two biotypes show opportunistic and 
different feeding behaviors. Another member of the complex, Culex quinquefasciatus is a 
noticeably domestic species and common in urbanized areas. Especially in towns with poor and 
inadequate drainage and sanitation, this mosquito breeds mainly in water polluted with organic 
matter (Harbach, 2012). 
The adult females of the Cx. pipiens complex bite humans and animals throughout the night, 
indoors and outdoors (Harbach, 2012). During the day, they are inactive and are often found 
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resting in dark corners of rooms and shelters. They may also rest outdoors on vegetation and in 
tree holes in forested areas (Harbach, 2012). 
 
Table 1. Behavioral and physiological traits associated with three nominal forms of the pipiens assemblage 
(Harbach, 2012). 
Trait pipiens molestus Cx. quinquefasciatus 
Host feeding ornithophilic, 
zoophilic 
anthropophilic, 
mammophilic, 
ornithophilic 
anthropophilic, 
mammophilic, 
ornithophilic 
Feeding location exophagic endo- / exophagic endo- / exophagic 
Resting location exophilic endo- / exophilic endo- / exophilic 
Egg development anautogenous autogenous anautogenous 
Mating space eurygamous stenogamous stenogamous 
Diapause heterodynamous homodynamous homodynamous 
Larval habitat clean water normally 
above ground 
clean / polluted water 
below ground 
clean / polluted / 
brackish water above 
ground 
 
5. Medical importance 
In several countries, members of Culex pipiens complex cause considerable nuisance, 
annoyance and irritation because of their troublesome bites. They are considered as main vectors, 
and sometimes reservoirs, of several medically important pathogens that infect humans including 
filarial worms, wild life pathogens such as avian malaria (Plasmodium species) and some 
arboviruses like Saint Louis Encephalitis Virus (SLEV), WNV, and RVFV. 
Culex pipiens fatigans (now referred as Culex quinquesfasciatus) was considered a vector of 
Bancroftian filariasis in East Africa (White, 1971). This species was found infected with 
microfilariae of Wuchereria bancrofti in North-Eastern Tanzania between 1968 and 1970 
(White, 1971). Culex pipiens mosquitoes were implicated as natural vectors of Dirofilariasis in 
Central Italy (Cancrini et al., 2007). In 2002-2003, mosquito collections were performed using 
dog-baited traps and Dirofilaria immitis and Dirofilaria repens were found in three pools of Cx. 
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pipiens (Cancrini et al., 2007). In addition, three pools of field-collected Cx. pipiens were found 
naturally infected with Dirofilaria immitis in Central Turkey (Yildirim et al., 2011). In addition, 
avian malaria parasites can be transmitted by Cx. pipiens species complex. Plasmodium parasites 
were detected in Cx. pipiens collected by bird-baited traps in 2004 in New York (Kimura et al., 
2010).  
In the United States, from 1977 to 1986, nine outbreaks of SLEV occurred (Monath and Tsai, 
1987) during which both Cx. pipiens and Cx. quinquefasciatus were found naturally infected 
with the virus (Monath and Tsai, 1987). Two strains of SLEV were isolated from overwintering 
Cx. pipiens mosquitoes collected in Maryland and Pennsylvania during January and February 
1977 (Bailey et al., 1978). Moreover, a Saint Louis encephalitis epidemic in Grand Junction, 
Colorado, occurred in 1985. No human cases were reported, but mosquito surveillance disclosed 
SLEV in Culex tarsalis and Culex pipiens pipiens field collected mosquitoes (Tasi et al., 1988). 
One of the predominant vectors of WNV is Cx. pipiens. Field-collected Cx. pipiens 
mosquitoes were found to be naturally infected with the virus in several countries in the world 
(Hubálek and Halouzka, 1999). WNV was isolated from Cx. pipiens mosquito pools in Romania 
(Tsai et al., 1998), Portugal (Almeida et al., 2008), Italy (Calzolari et al., 2010), Egypt (Soliman 
et al., 2010), Israel (Orshan et al., 2008), Greece (Papa et al., 2013; Patsoula et al., 2016), and 
Turkey (Ergunay et al., 2013). Hubalek and Halouzka (1999) mentioned in their review that 
WNV was also isolated from Cx. pipiens in South Africa, Czech Republic and Bulgaria. In 
addition, the same authors stated that WNV was as well isolated from Cx. quinquefasciatus in 
India, Pakistan, and Madagascar. Moreover, a study conducted by Andreadis (2012) showed that, 
WNV isolated from field collected Cx. quinquefasciatus mosquito pools were predominant in 
Southeast and Southwest United States, while Cx. pipiens was the predominant vector of WNV 
18 
 
in northeastern United States (Andreadis, 2012). Furthermore, a study showed that Cx. pipiens 
mosquitoes were able to vertically transmit WNV (Dohm et al., 2002). This type of transmission 
amplifies the virus and increases the transmission risk.  
Cx. pipiens complex is also considered a secondary vector of RVFV. Some countries 
reported field-collected Cx. pipiens mosquitoes naturally infected with the virus (Tantely et al., 
2015). RVFV was successfully isolated from Cx. pipiens mosquitoes in Egypt (Hoogstraal et al., 
1979) and Sudan (Seufi and Galal, 2010). In addition, the virus was isolated from Cx. 
quinquefasciatus in Kenya (Sang et al., 2010). 
Cx. pipiens was indicated as a suspected vector of Usutu virus (USUV). In Italy, USUV was 
detected in 54 Cx. pipiens pools (Calzolari et al., 2010). Moreover, sequences of this virus were 
found in one pool of this species in Spain in 2006 collections (Busquets et al., 2008). 
 
6. Mosquito control methods and challenges 
Mosquito control manages medically important mosquito populations including Culex 
pipiens in order to reduce their impact on human health, economies, and pathogen transmission. 
Several mosquito control measures are directed at either the immature aquatic stages of the 
mosquito or the adults using environmental management, physical, biological, chemical and 
genetic methods. In addition, personal protection measures that limit people contact with adult 
mosquitoes are also implemented. It is a key component in the prevention of mosquito nuisance 
and mosquito-borne diseases. Measures may include: simply staying indoors, wearing clothing 
that minimizes exposed skin, use of personal repellents on skin or clothing, and use of 
Insecticide treated nets (ITN) (Becker et al., 2010; Service, 2007). 
19 
 
Several environmental management concepts aiming to reduce mosquito breeding sites can 
be applied, but these measures differ between urban and rural areas and may sometimes be 
difficult to implement especially in urban areas (Becker et al., 2010). Habitats for many 
mosquito species can be diminished by monitoring and eliminating wide range of water bodies 
and also by, appropriately designing urban structures and sanitation to prevent formation of 
breeding sites. 
Several physical control techniques exist for both immature aquatic mosquito stages and 
adults. For example, larvae and pupae can be suffocated and deprived from water tension using 
polystyrene beads and monomolecular surface films. Physical control techniques are attractive 
since they are effective against mosquitoes resistant to conventional insecticides. 
Biological control is performed by the reduction of the target mosquito population, to an 
“acceptable” level, by the use of predators, parasites, pathogens, competitors, or toxins from 
microorganisms. These measures are mostly efficient against the immature aquatic stages of the 
mosquito, for which some vertebrate and invertebrate predators can be used successfully such as 
the mosquito fish (Gambusia affinis), amphibians, birds and several others (Becker et al., 2010). 
Pathogens such as fungi can also be adopted targeting larval stages of mosquitoes. These 
measures must be controlled in order to maintain biodiversity and seek for the minimal impact 
on the environment. The use of toxins such as Bacillus thuringiensis toxin (Bti), is largely 
adopted in many industrialized countries. This environmentally safe product remains expensive 
and therefore rarely used in low-income regions. 
The development of chemical insecticides has led to many major advances in mosquito 
control. Several families of insecticides are used indoors or outdoors: chlorinated hydrocarbons 
(organochlorines), organophosphates (OP), carbamates, and pyrethroids, and a special class 
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referred to as insect growth regulators (IGRs) (Becker et al., 2010). According to the World 
Health Organization Pesticide Evaluation Scheme (WHOPES), the most used organochlorine in 
the African region is Dichlorodiphenyltrichloroethane (DDT). In other regions, the most used 
insecticides are the organophosphate Malathion and the pyrethroid Permethrin. The carbamate 
Propoxur is also used for indoor residual spraying (IRS). There are two major groups of IGRs 
that differ in their mode of action. The first is the chitin synthesis inhibitors which interfere with 
new cuticle formation, resulting in moult disruption (Becker et al., 2010). The second is the 
juvenile hormone analogs that interfere with the metamorphic processes affecting development 
to the adult stage (Becker et al., 2010). 
The main constraint remains the difficulty to target the adult and larval stages in their resting 
or breeding sites. The auto-dissemination approach is a relatively new approach that aims to 
better target the adult stage. It is based on exposing wild females to artificial resting sites 
contaminated with pyriproxyfen. Then females can disseminate this juvenile hormone analogue 
to larval habitats, thus interfering with adult emergence. This approach was applied on Aedes 
aegypti and Aedes albopictus (Caputo et al., 2012; Devine et al., 2009). It was also 
experimentally tested on Cx. quinquefasciatus populations and provided very promising results 
(Mbare et al., 2014). 
Over time, repeated uses of insecticides lead to the development of insecticide resistance, 
especially to organochlorines and organophosphates, becoming a problem in several mosquito 
populations and particularly in Culex pipiens in different countries including Lebanon (Osta et 
al., 2012), Iran (Salim-Abadi et al., 2016) and the USA (Paul et al., 2005). This resistance 
became a limiting factor for the efficacy of control efforts. 
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Today, genetic control of mosquitoes relies on two main fronts. The first consists of Sterile 
Insect Technique (SIT) that aims to eliminate an entire population of a particular mosquito 
species. One example is the sterile male technique or male sterilization that consists of releasing 
a mass of modified male mosquitoes that mate with indigenous females to produce no fertile 
offspring. The second is the population replacement consisting to replace wild populations by 
genetically-modified mosquitoes rendered refractory to a pathogen (Becker et al., 2010). 
SIT is currently in operational use more than the population replacement technique. In 
Florida, in 1969, Culex quinquefasciatus populations were successfully suppressed and 
eliminated after the massive release of chemo-sterilized males (Patterson et al., 1970). In France, 
in 1970, a reduction in Cx. pipiens populations was obtained after the release of hundred 
thousand sterile specimens following chromosomal translocation (Laven et al., 1971). More 
recently, in La Reunion Island, a field test was implemented to control Aedes albopictus 
populations; a two-fold reduction of the wild population fertility was obtained after the release of 
males sterilized by irradiations with Cesium-137 (Oliva et al., 2012). 
In addition, recent work has shown that the introduction of an over replicating strain 
(wMelPop) of the bacteria Wolbachia into Ae. aegypti can lead to a cytoplasmic incompatibility 
and inhibits the dissemination of Dengue Virus (DENV) as well as Chikungunya Virus (CHIKV) 
(Moreira et al., 2009). The release of Aedes specimens infected with appropriate strains of 
Wolbachia was proposed to control Zika Virus (ZIKV) in Brazil (Callaway, 2016). However, the 
use of Wolbachia to reduce transmission of pathogens by Culex species must be studied 
carefully. Indeed, a recent study demonstrated that the transmission of WNV could be improved 
by the presence of the Wolbachia strain wAlbB in the mosquito Culex tarsalis (Dodson et al., 
2014).  
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Chapter 2 
West Nile Virus 
 
West Nile Virus (WNV), an arthropod-borne virus, is the causative agent of West Nile Fever 
(WNF). This virus is transmitted from infected birds to humans by the bite of a broad range of 
mosquito species, but mainly members of the Culex genus, most importantly Culex pipiens 
complex species. 
 
1. Transmission cycle 
In an enzootic cycle, mosquitoes get infected by feeding on a bird having a sufficiently high 
viremia. The virus then replicates inside the mosquito before it infects another host (Figure 6). 
Vertical transmission by mosquitoes provides the mechanism of virus overwintering (Chancey et 
al., 2015). Only females having high natural infection titers succeeded to pass WNV to their 
overwintering adult progeny (Nelms et al., 2013). Migratory birds ensure the seasonal spread of 
the virus between countries. Thus, mosquito species feeding on these infected birds during their 
stopovers transmit the virus to local bird species. Transmission to people and horses is 
accidental; it occurs when an infected mosquito feeds on a person or a horse thereby transmitting 
the virus via its salivary gland secretions. People and horses are dead end hosts because they do 
not develop viremia high enough to infect a mosquito. Experimental infections of horses with the 
NY99 strain of WNV revealed low viremia levels (a maximum viral titer of 103 plaque forming 
units (PFU)/mL) of short duration and all mosquitoes that fed upon viremic horses were not able 
to transmit the virus (Bunning et al., 2002). Therefore, infected horses are unlikely to serve as 
important amplifying hosts for WNV in nature. In fact, infectious doses required to infect Cx. 
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pipiens should be greater than 105 PFU/mL (Turell et al., 2000). Horizontal transmission between 
birds is possible in cases of fecal or oral fluids contact (Van der Meulen et al., 2005). WNV can 
also be transmitted between humans by blood transfusion, organ transplantation, transplacental 
transmission, and via breast milk. 
 
 
Figure 6. WNV transmission cycle (Chancey et al., 2015). 
 
Birds are presumed to be the most important amplifying hosts of WNV. In laboratory studies, 
bird species of Passeriformes, Charadriiformes, Strigiformes (owls), and Falconiformes 
developed viremia levels sufficiently high to infect most feeding mosquitoes (Komar et al., 
2003). Birds like house sparrows (Passer domesticus) which are common in many countries 
including Lebanon, develop high viremia and therefore contribute to mosquito infection without  
developing clinical symptoms (Komar et al., 2003). 
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2. Geographic distribution 
WNV was first isolated from a febrile woman in Uganda in 1937 (Smithburn et al., 1940). 
WNV infections have been reported in many tropical and temperate countries in Africa, Europe, 
Asia and America. The circulation of this virus is being continuously traced by eCDC (Figure 7). 
The Middle East and North Africa (MENA) region has been long considered as a WNV-endemic 
area in which hundreds to thousands of human and equine cases have occurred. A series of 
outbreaks from the 1990s brought WNV into the spotlight. Epidemics in Algeria, Morocco, 
Tunisia, Italy, France, Romania, Israel, and Russia were associated with uncharacteristically 
severe human disease, including neurologic complications and death (Marka et al., 2013; 
Murgue et al., 2001a; Platonov et al., 2001; Tsai et al., 1998). Recent outbreaks have affected 
Israel in 2000 (Weinberger et al., 2001), Greece in 2010 (Danis et al., 2011) and 2011 (Vrioni et 
al., 2014), and Turkey in 2010 (Kalaycioglu et al., 2012). In addition, evidence of recent human 
WNV circulation has been reported in Libya (Shaibi et al., 2017), Jordan (Batieha et al., 2000), 
Egypt (Soliman et al., 2010) and Israel (Kopel et al., 2011). 
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Figure 7. Past and present WNV transmission activities in the Euro-Mediterranean region (eCDC, 2017). 
 
The introduction of WNV into the United States of America (USA) in 1999 which constitutes 
a turning point in WNV epidemiology, is thought to have originated from Israel following 
introduction from Africa (Giladi et al., 2001; Lanciotti et al., 1999). In the summer 2001, the 
virus was found in 10 states and WNV continued to spread until a large outbreak that occurred in 
2006, with 177 deaths and 1495 cases of West Nile neurological disease (WNND) out of a total 
of 4260 cases (WHO, 2017). Through 2010, it was estimated that 1.1% of the United States 
population had been infected by WNV (WHO, 2017). 
The presence of WNV was first discovered in Europe in 1958 in Albania with detection of 
neutralizing antibodies in human sera (Hubálek and Halouzka, 1999). The first documented 
outbreak of WNV occurred in southern France in 1962-1963, causing WNND in both humans 
and horses (Murgue et al., 2001a). Notable outbreaks with human cases include the reemergence 
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of WNV in France in 2000-2003, Italy in 2008-2009, and Hungary in 2008 (Bakonyi et al., 2013; 
Calistri et al., 2010; Di Sabatino et al., 2014; Zeller and Schuffenecker, 2004). Recently, human 
WNV cases were reported in several European countries. 
Epizootics in horse populations occurred in Morocco in 1996 in which 94 cases in equines 
(including 42 deaths) and 1 case in a human were reported (Schuffenecker et al., 2005). During 
the late summer of 1998, veterinary authorities in Tuscany, Italy, received reports of neurologic 
disease cases among horses (Autorino et al., 2002). In 2000 in USA, 63 horses with neurologic 
and other illnesses due to WNV infection were reported from 26 counties in seven states (Marfin 
and Gubler, 2001). Cases were reported in France in 2000, where WNND cases were confirmed 
in 76 horses, and 21 of them died (Murgue et al., 2001b). Recent equine outbreaks occurred in 
Italy in 2008 (14 horse cases), Hungary in 2008 (12 equine neuroinvasive cases) (Angenvoort et 
al., 2013). Since 2010, WNV infections among horses were repeatedly reported in the 
Mediterranean basin and other European countries, namely Algeria (Lafri et al., 2017), Jordan 
(Abutarbush and Al-Majali, 2014), Bulgaria, Czech and Slovak Republics (Hubálek et al., 2013), 
Croatia, Greece, Italy, Spain (Abad-Cobo et al., 2016; Jiménez-Clavero et al., 2010), Macedonia, 
Morocco, Portugal (Barros et al., 2011), and Romania (Angenvoort et al., 2013). 
WNV has been detected in more than 150 species of wild and domestic birds worldwide. The 
susceptibilities of birds to WNV infection differ among bird species. Severe disease and deaths 
were not reported in natural WNV infections of birds until 1998, when an outbreak occurred in 
Israel, during which 160 of 400 domestic goslings developed fatal encephalitis (Di Sabatino et 
al., 2014). In 1999, during the outbreak of WNV in USA, thousands of deaths in more than 150 
species of native and exotic birds were detected (Nash et al., 2001; Steele et al., 2000). In the 
following years, bird infection with WNV and sometimes death were observed in several 
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countries around the world. During the summers of 2004-2005 in Southeast Hungary, the first 
clinical cases were described and WNV infections in birds were detected. It corresponds to the 
first evidence of a neuroinvasive WNV lineage 2 circulation in continental Europe (Erdélyi et al., 
2007). Subsequently, a similar WNV lineage 2 strain was molecularly identified and 
characterized from an Eurasian magpie hunted in Greece in 2010, during a WNV outbreak in 
humans (Valiakos et al., 2011). 
In a serosurvey study conducted in Camargue France, a low WNV seroprevalencewas 
observed among birds in a 3-year period (2005-2007). It revealed the existence of an enzootic 
activity of WNV without any detectable emergence of an epizootic (Balança et al., 2009). 
Moreover, in Germany during 2005-2009, a study discovered WNV-neutralizing antibodies in 10 
species of migratory birds, but not in resident birds (Seidowski et al., 2010). For the first time in 
Serbia, WNV lineage 2 RNA were detected by RT-qPCR in pooled tissue samples of 
investigated birds in 2012 (Petrović et al., 2013). 
 
3. Classification and lineages distribution 
West Nile Virus (WNV) belongs to the Flavivirus genus that includes the largest number of 
viral species compared to other genera (Pestivirus and Hepacivirus) composing the Flaviviridae 
family. The Flavivirus genus includes at least 53 species divided into 12 serogroups. WNV 
belongs to the Japanese Encephalitis Virus (JEV) group that comprises eight viral species, 
among which we cite, in addition to WNV, JEV, SLEV, Murray Valley Encephalitis that are 
frequently associated with widespread human and animal disease outbreaks (Schweitzer et al., 
2009). 
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WNV is a genetically and geographically diverse virus. Up to nine distinct WNV genetic 
lineages with inconsistent numbering, have been proposed in the literature based on phylogenetic 
analyses of the complete genome or of the NS5 gene. Their genomes differ from each other by 
more than 20-25% and correlate well with the geographical point of isolation. Rizzoli and 
collaborators (2015) suggested a harmonized lineage numbering into seven lineages (Figure 8). 
Lineages 1 and 2 of WNV have been associated with significant outbreaks in humans (Chancey 
et al., 2015). 
 
 
Figure 8. Phylogenetic tree of WNV lineages based on complete genome sequences (Rizzoli et al., 2015). 
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Lineage 1 is the most widespread, containing isolates found in Europe, North America, Asia, 
Africa and the Middle East (Chancey et al., 2015; Rizzoli et al., 2015). This linage is further 
divided into different clades: WNV-1a is found mainly in Africa, Europe, North America and 
Asia (May et al., 2011). WNV 1-b contains the Australian Kunjin virus (May et al., 2011). Clade 
1c of lineage 1, formerly considered lineage 5, includes isolates from India (Bondre et al., 2007; 
Rizzoli et al., 2015). 
Lineage 2 strains are mainly distributed in Sub-Saharan Africa and Madagascar, and detected 
in humans and horses (Venter and Swanepoel, 2010). But in the last decade, Lineage 2 WNV has 
been introduced in Europe. Ciccozzi and collaborators (2013) suggest, based on E and NS5 gene 
analysis, that there were at least two introductions of this lineage to Central Europe in 1999 and 
to Russia in 2000 from the African continent. Since 2004, strains have been observed in Hungary 
from birds of prey (Bakonyi et al., 2006). In 2010, it caused outbreaks in Romania and Greece 
(Valiakos et al., 2011) and in 2011, it was detected for the first time in Italy (Ciccozzi et al., 
2013).  
Lineage 3 contains strains circulating in certain Culex and Aedes mosquito species in 
southern Moravia, Czech Republic; and it is not known to be pathogenic to mammals (Bakonyi 
et al., 2006). Lineage 4 comprises three clades of viruses as well: clade 4awasdetectedin a tick 
specimen from the Caucasus (May et al., 2011). Clade 4b, previously noted as lineages 6 and 7, 
contains a number of isolates from Culex pipiens mosquitoes captured in Spain in 2006 (Vazquez 
et al., 2010). And, Clade 4c, previously classified as lineage 9, comprises viral strains isolated 
from Uranotaenia mosquitoes in Austria (Rizzoli et al., 2015). A re-classification of Sarawak 
Kunjin virus as lineage 6 has been proposed as this strain is different from other Kunjin viruses 
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(Lineage 1-b). Lineages 6 (called Koutango virus) and 7 comprise isolates of the virus from 
Senegal (Chancey et al., 2015; Rizzoli et al., 2015). 
 
4. Virus description and genome structure 
WNV virion is a 50 nm icosahedral particle, enveloped by a lipid bilayer (Figure 9). It has a 
single stranded positive-sense RNA genome of approximately 11 kb (Knipe and Howley, 2013). 
The virion presents a host-derived lipid membrane surrounding a nucleocapsid core (Knipe and 
Howley, 2013). The envelope, derived from the host cell membrane, is composed of two virally 
derived major proteins: protein E (association with the outer viral envelope) and protein M. The 
protein E is a viral hemagglutinin and the primary target of the host immune response while the 
protein M acts as a stabilizing factor to protect the protein E as it is transported from the infected 
cell during replication (Schweitzer et al., 2009). 
 
 
Figure 9. WNV genome organization and virion composition: (a) the viral genome is represented with one 
Open Reading Frame that includes 10 genes: 3 encode for structural proteins and 7 for nonstructural 
proteins. (b) Structure of WNV virion showing membrane and capsid proteins enveloping the RNA (Chancey 
et al., 2015). 
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The genome contains 10 genes flanked by 5’ and 3’ non coding regions (NCR) without a 
polyadenylation tail at the 3’ end (Knipe and Howley, 2013). WNV genome has a single open 
reading frame (ORF) and encodes one large polyprotein that is co- and post-translationally 
processed and cleaved into 3 structural proteins that are encoded in the 5’ end of the genome, and 
7 non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) proteins that are encoded in 
the 3’ end (Knipe and Howley, 2013). 
Structural proteins of WNV include: the nucleocapsid protein (C); a precursor glycoprotein 
(prM) that is cleaved during virus maturation to yield the transmembrane protein (M); and the 
major spike glycoprotein of the envelope (E) (Knipe and Howley, 2013). The nucleocapsid is 
composed of C protein, which associates with the RNA genome and mediates viral assembly 
(Knipe and Howley, 2013). Heterodimers of prM and E protein become embedded in the lipid 
bilayer of the virus during assembly and are exposed on the virion surface until cleavage during 
the viral maturation process (Knipe and Howley, 2013). The E protein mediates binding of the 
receptor on the cell surface for viral entry. It also helps fusion with the membrane of the host cell 
and is considered the major target for neutralizing antibodies (Knipe and Howley, 2013). 
All seven non-structural proteins appear to be directly or indirectly involved in viral RNA 
synthesis. NS1 plays an early role in regulation of viral RNA replication (Knipe and Howley, 
2013). NS2A, NS2B, NS4A, and NS4B are small, hydrophobic proteins that do not have 
conserved motifs characteristic of known enzymes. NS3 has multiple enzymatic functions, 
serving as a viral serine protease which cleaves the other non-structural proteins from the viral 
polyprotein, in association with NS2B; and an RNA helicase in association with NS4A (Knipe 
and Howley, 2013). NS5 is the C-terminal protein of the viral polyprotein and is the largest and 
most conserved of the mature flavivirus proteins. It is necessary for viral replication, containing 
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RNA-dependent RNA polymerase activity in the C-terminal region and methyltransferase 
activity in the N-terminal region (Knipe and Howley, 2013). 
The presence of the envelope makes WNV, like other Flaviviruses, susceptible to organic 
solvents. Moreover, these viruses are easily inactivated by heat and by common disinfectants 
(Knipe and Howley, 2013; Maclachlan and Dubovi, 2010). 
 
5. Replication 
WNV replicates well and cause cytopathic changes in many cell cultures such as Vero cell 
line (African green monkey kidney), and mosquito cell line (C6/36). Cellular attachment appears 
to be mediated by ligands on the E glycoprotein(s), although cellular receptors have not been 
unambiguously identified (Figure 10). After attachment, the viruses enter cells via receptor-
mediated endocytosis. In the endosome, E proteins fuse the viral membrane with the endosomal 
vesicle membrane then release the nucleocapsid into the cytoplasm (Figure 10A). The genomic 
RNA is released from the capsid by an unknown mechanism and is translated (Figure 10B). The 
polyprotein is co- and post-translationally cleaved at multiple sites to generate the mature viral 
proteins (Figure 10C). The viral RNA dependent RNA polymerase (from the NS5 protein) copies 
complementary negative polarity strands from the positive polarity genomic RNA template 
(Figure 10D). The newly formed negative strand RNAs serve as templates for the synthesis of 
new genomic RNAs (Figure 10E). Virion assembly occurs in association with rough 
endoplasmic reticulum membranes (Figure 10F). Intracellular immature virions containing 
heterodimers of E and prM accumulate in vesicles and are then transported through the host 
secretory pathway where E and prM glycans are modified (Figure 10G). A portion of prM on 
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immature virions is cleaved in the trans-Golgi network and at the end, virions are transported to 
the plasma membrane in vesicles and released by exocytosis (Figure 10H) (Diamond, 2009). 
 
 
Figure 10. The replication cycle of WNV. The virus attaches to cell membrane, enters the host cell and 
releases the RNA that is translated and copied (A-C). The viral RNA negative and positive polarity are copied 
using viral RNA polymerase (D-E). The newly formed virions assemble with the endoplasmic reticulum 
membrane (F) then they are cleaved by the Golgi network (G). Finally virions are transported by vesicles and 
secreted by exocytosis (H) (Diamond, 2009). 
 
6. Pathogenesis 
The majority of WNV infections in humans are asymptomatic. Approximately, 20 to 30% of 
infected individuals develop flu-like clinical manifestations as an acute febrile illness 
accompanied by headache, polyarthropathy, rash and lymphadenopathy (Knipe and Howley, 
2013). But WNV is also able to cause a neuroinvasive disease (WNND) in a limited 
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subpopulation of individuals (approximately 1 in 150). The clinical features of severe WNV 
infection vary and include muscle weakness, cognitive impairment, tremors, and a poliomyelitis-
like flaccid paralysis. In some cases, infections can lead to encephalitis, causing long-term 
disability and rarely leading to death (Knipe and Howley, 2013). 
Horses, just like humans, are dead-end hosts, meaning that while they become infected, they 
do not spread the infection. Horses infected with WNV mostly show no symptoms or rarely 
acquire mild febrile illness. However, neuroinvasive (encephalomyelitis) forms are also reported. 
In these cases, the disease shows reserved prognosis and 30-40% of horses would die 
(Maclachlan and Dubovi, 2010). Horses affected by West Nile Encephalitis (WNE) are usually 
euthanized. Many horses that recover from WNE have been reported to have some residual 
neurological deficits, such as gait abnormalities and a change in their usual temperament or 
behavior. The signs and course of the disease are highly variable since not all infected horses 
react similarly. Horses may become abnormally sensitive to sights, sounds, or touch. They may 
present signs of discomfort or anxiety, low-grade fever, or malaise. Neurologic signs can include 
muzzle twitching, impaired vision, trembling, lack of coordination, and muscle contractions. The 
most severe cases evolve to paralysis of the hind legs, terminal convulsion and death 
(Maclachlan and Dubovi, 2010). 
In Europe, Africa, Middle East and Asia, mortality in birds associated with WNV infection is 
rare. In contrast, the virus is highly pathogenic for birds in USA (Maclachlan and Dubovi, 2010). 
Infection may result in a very high viremia titer and widespread necrosis, hemorrhage, and 
inflammation in several organs including heart, lungs, spleen, liver, kidney, and nervous system. 
These severe infections might lead to death (Maclachlan and Dubovi, 2010). In Serbia, evidence 
of  WNV circulation (neutralizing antibodies or viral RNA) was reported in several bird species 
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such as Northern Goshawks (Accipiter gentilis), White-tailed Eagles (Haliaeetus albicilla), 
Legged Gull (Larus michahelis), Hooded Crow (Corvus cornix), Bearded Parrot-bill (Panarus 
biramicus), and Common Pheasant (Phasianus colchicus) (Petrović et al., 2013). In Southern 
France and Southern Spain, House sparrow (Passer domesticus) and Magpie (Corvidae family) 
birds were found infected with WNV (Balança et al., 2009; Ferraguti et al., 2016). In USA, 
Corvid species appear to be susceptible for WNV infection. Following the large outbreak in 
1999, crows in addition to flamingos were found highly infected with this virus (Steele et al., 
2000). 
 
7. Diagnosis 
The clinical signs of WNV infection among humans and horses are characteristic but not 
pathognomonic. Routine clinical laboratory analysis do not distinguish WNV infection from 
many other viral infections. Thus the diagnosis must be confirmed by further laboratory tests 
based on the detection of WNV RNA in blood and cerebrospinal fluid (CSF) or virus isolation in 
cell culture from serum samples (direct diagnosis) or the detection of a specific immune response 
against the virus (indirect diagnosis) (Rizzoli et al., 2015). 
To date, the most consistent manner to verify WNV infection is serology (Rossi et al., 2010). 
Serological tests are performed on serum or cerebrospinal fluid (CSF) of acute or convalescent 
cases to determine the WNV specific antibody profile by ELISA. In order to detect recent 
infections, the test involves immunoglobulin M antibodies IgM-specific ELISA in which serum 
is collected within 8 to 21 days after the appearance of clinical symptoms. This test provides 
strong evidence of recent WNV infection. For seroprevalence studies, immunoglobulin G (IgG) 
antibodies are seeked out by ELISA. One disadvantage of ELISA test is cross-reactivity with 
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infections caused by other Flaviviruses. Thus, Plaque reduction neutralization test (PRNT) is the 
gold standard method  used for further confirmation of WNV infection (Rossi et al., 2010). 
Moreover, virology tests can directly confirm the presence of the virus in patient serum or 
CSF. The virus is first amplified within permissive cells (such as Vero cells) and then the viral 
identity is confirmed by molecular methods. Nevertheless, molecular tools can be directly 
employed to confirm the presence of virus (or its RNA). Different quantitative reverse 
transcription polymerase chain reaction (RTqPCR) protocols have been developed to amplify 
minimal amounts of WNV RNA. But, viraemia is short-lived in dead-end hosts, so detection of 
viral genomes becomes increasingly challenging over time. Recent studies demonstrated that 
WNV RNA can be detected in urine much longer (up to 20 days after the onset of symptoms) 
and at higher concentrations than in serum or CSF in individuals infected with WNND (Rizzoli 
et al., 2015). But the problem of PCR remains in certain protocols to miss some circulating 
WNV lineages, therefore a multiplex PCR is advised in order to avoid such issues (Rizzoli et al., 
2015). 
The presence of reactive lymphocytes or monocytes in CSF samples is indicative of WNV 
neurologic infection. In patients with WNV neuroinvasion, more than 40% of cells in the CSF 
are neutrophils. Furthermore, Magnetic Resonance (MR) imaging suggests abnormalities in the 
brain and meninges of WNV infected patients presenting a central nervous system disease (Rossi 
et al., 2010). 
 
8. Treatment and vaccine development 
Treatment for WNV infections is mainly supportive. No specific antiviral therapy is 
available. Management is focused on pain control and inflammation. There are no licensed 
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human WNV vaccines, but there are multiple equine vaccines. The development of safe and 
effective vaccines against WNV remains as a high priority. The only preventive methods to limit 
the spread of WNV are based on controlling the vector population and on vaccinating horse 
populations in endemic countries. Vector control is performed using several techniques such as 
personal prevention, the use of insecticides, impregnated bed nets and the implementation of 
some challenging genetic control protocols. 
Three vaccine formulations are currently available for prevention of WNV in equids: two are 
inactivated vaccines and one is a non-replicating live canary pox recombinant vector vaccine (De 
Filette et al., 2012). The first licensed vaccine contains a formalin-inactivated whole WNV. This 
vaccine is currently commercialized in USA under the trade name West Nile-Innovator®. 
Another killed virus vaccine (Vetera® WNV vaccine) was developed and licensed. A third 
commercialized WNV vaccine in USA for horses is Recombitek® Equine West Nile Virus 
Vaccine which is a chimeric recombinant canary poxvirus vaccine. It expresses the prM and E 
genes derived from a 1999 New York isolate of WNV (De Filette et al., 2012). Administration, 
dosage and vaccination schedule differ between these three vaccines. 
Although no approval from FDA (Food and Drug Administration) was obtained, vaccines for 
human use exist and currently, there are a number of ongoing clinical trials. There are several 
strategies being pursued for WNV vaccine development for humans including inactivated, 
recombinant live virus, chimeric virus (ChimeriVax-WN), DNA, and recombinant subunit 
vaccines (De Filette et al., 2012). ChimeriVax-West Nile vaccine (Acambis, Sanofi-Pasteur) 
utilizes the attenuated Yellow Fever Virus (YFV) vaccine strain to build a live chimeric virus 
that consists of the prM and E proteins of WNV in the context of the YFV capsid and non-
structural proteins. It is the most advanced vaccine in development, and currently, it has 
38 
 
progressed beyond the second part of clinical phase II trial (De Filette et al., 2012). Although the 
live vaccine candidates induced high humoral and cell-mediated immune responses similar to 
that obtained with wild-type WNV, vaccination has raised some safety concerns in susceptible 
individuals (De Filette et al., 2012). Long-term immunogenicity, safety and cost effectiveness are 
the most important problems in current development of vaccines against WNV and potential 
candidates for use in humans. 
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Chapter 3 
Rift Valley Fever Virus 
 
Rift Valley Fever Virus (RVFV) is a mosquito-borne virus that affects humans and livestock. 
The main enzootic vectors belong to the Aedes genus. However, several Culex species, including 
Cx. pipiens are considered secondary vectors and contribute to the transmission of the virus. 
 
1. Transmission cycle 
RVFV circulates following two types of cycles: an enzootic cycle that occurs during the 
average rainfall season and an epizootic-epidemic cycle that occurs during the heavy rainfall 
season (Figure 11). During the enzootic cycle, the virus is maintained through transovarial 
transmission between the female mosquito belonging to the Aedes genus and her eggs and 
occasionally, through amplification in a vertebrate host such as African buffaloes. During the 
epizootic-epidemic cycle, the virus is over-amplified with massive hatching of Aedes eggs 
(including those RVFV-infected) following an abnormally high rainfall or floods. Obtained 
infected adults will infect susceptible livestock triggering an epizootic phase. A very high level 
of viremia is maintained for 3 to 5 days in infected sheep and cattle, allowing many more 
mosquitoes to become infected when feeding on infected animals. These mosquitoes may be 
transported for long distances in low level wind or air currents, which may lead to the rapid 
spread of the virus from region to region. Humans can become infected following the bites of 
Aedes (as a primary vector) or Culex (as a secondary vector) mosquitoes but the majority of 
human cases are thought to result from handling infected fluids and tissues: blood, secretions or 
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excretions of infected animals, notably after abortion via contaminated placentae (Maclachlan 
and Dubovi, 2010). 
 
 
Figure 11. RVFV transmission cycle. An enzootic (sylvatic) cycle occurs during the average rainfall season in 
which the virus is maintained through transovarial transmission and through amplification in a vertebrate 
host. An epizootic-epidemic (domestic) cycle occurs during the heavy rainfall season in which the virus is 
over-amplified with massive hatching of mosquito eggs (FAO, 2017). 
 
2. Geographic distribution 
RVFV was first identified in an outbreak of abortions and deaths in wool sheep and illness in 
humans that occurred in the Rift Valley of Kenya after heavy rainfalls in 1930-1931 (Daubney et 
al., 1931).  
Since then, outbreaks have been reported in the African region extending from sub-Sahara 
(Himeidan et al., 2014) up to Mauritania (El Mamy et al., 2011) (Figure 12). In Egypt in 1977, 
RVF was introduced via infected livestock trade along the Nile irrigation system and caused a 
large outbreak among both animals and humans resulting in over 600 human deaths (Meegan, 
1979). Another example of RVF spillover into human populations occurred in West Africa in 
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1987, and was linked to construction of a dam on the Senegal river (Guillaud et al., 1988). The 
project caused flooding in the lower Senegal River area, altering ecological conditions and 
interactions between animals and humans. As a result, a large RVF outbreak occurred in animals 
and humans. In 1997-1998, a major outbreak occurred in Kenya, Somalia and Tanzania 
following El Niño event and extensive flooding (Woods et al., 2002). Following infected 
livestock trade from the horn of Africa, RVF spread in September 2000 to Saudi Arabia and 
Yemen (Ahmad, 2000; Madani et al., 2003), marking the first reported occurrence of the disease 
outside the African continent and raising concerns that it could extend to other parts of Asia and 
Europe. 
 
 
Figure 12. RVFV geographic distribution (CDC, 2017). 
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During this outbreak, 516 cases with 87 deaths of RVF were reported by the Ministry of 
Health of Saudi Arabia while the Ministry of Public Health in Yemen reported 1087 suspected 
cases including 121 deaths (Ahmad, 2000; CDC, 2017; Madani et al., 2003; WHO, 2017). The 
African continent remains the most affected. Outbreaks continue to be reported from different 
countries. In 2003 in Egypt, there were 148 cases including 27 deaths of RVF reported by the 
Ministry of Health of Egypt (CDC, 2017; WHO, 2017). Several other outbreaks occurred in 
Kenya (2006, 2007), Tanzania (2007), Somalia (2007), Sudan (2007), Madagascar (2008, 2009), 
and Republic of South Africa (2010) (CDC, 2017; WHO, 2017). 
In October and November 2010, an outbreak of RVF was reported in the northern part of 
Mauritania (El Mamy et al., 2011). Cases in animals and humans seemed to occur shortly after 
intense and unusual rainfalls (Faye et al., 2014). Severe clinical signs and high mortality was 
described among camel. At least, 63 human cases were noted including 13 deaths (Faye et al., 
2014). RVFV strains were isolated from  humans and also from Cx. antennatus mosquitoes 
(Faye et al., 2014). In 2012, a large but unspecified number of ruminants were affected, together 
with more than 34 human cases, including 17 deaths, from six regions in Mauritania. Most of the 
human cases had a history of contacts with animals or sick animals (Sow et al., 2014). Then, 
from September 2013, domestic ruminants and humans from Senegal were tested positive for 
RVFV by RT-PCR in several regions (Sow et al., 2016). The outbreak coincided with 
preparations for the annual Muslim celebration (Sow et al., 2016). From September to November 
2015, 31 hospitalized patients who presented severe clinical forms of RVF disease were 
subsequently tested positive for the virus. At least, eight people died (Boushab et al., 2016). 
Most recently, in 2016 in Uganda, CDC localized an outbreak of three confirmed and two 
probable human cases. In addition, in August 2016, health authorities in Niger reported cases of 
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febrile illness, including hemorrhagic symptoms, in humans, as well as sickness and abortions in 
ruminants. Subsequent diagnostic testing confirmed 17 RVF human cases and 33 deaths (CDC, 
2017). 
 
3. Classification and lineages distribution 
RVFV belongs to the Bunyaviridae family, Phlebovirus genus comprising 70 viruses that can 
be divided in 2 groups: the sandfly fever virus group and the Uukuniemi-like virus group (Elliott 
and Brennan, 2014). There are important differences between these groups; notably that the 
Uukuniemi-like viruses do not encode a nonstructural protein and they are all transmitted by 
ticks. The sandfly fever group are transmitted by dipterans (phlebotomines and mosquitoes). This 
group contains important human and animal pathogens, including RVFV and the sandfly fever 
viruses (Maclachlan and Dubovi, 2010). 
A number of studies on the genetic diversity of RVFV have been published over the past 
years revealing an increasing number of lineages. These studies showed that the genetic diversity 
of RVFV across all lineages is limited, with maximum pair-wise differences for the S segment 
and M segments of 4% and 5.4% for the nucleotide sequence and 1% and 2.8% for the amino 
acid sequence, respectively. 
Extensive analysis of the complete genomes (S, M, and L segments) of 33 diverse RVFV, via 
high-throughput technique, showed that this virus can be separated into 7 distinct genetic 
lineages (A to G) (Bird et al., 2007). RVFV strains with diverse geographic origins can be found 
in each lineage, which is indicative of widespread dispersal and movement of the virus 
genotypes throughout Africa.  
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Grobbelaar and collaborators (2011) analyzed five derived strains and 198 isolates of RVFV 
that have circulated over 67 year period. It showed that despite low genetic diversity, these 
isolates resolved into 15 lineages (A–O): Six lineages (B, D, F, J,  O and I) contained isolates 
from South Africa, six other lineages (A, C, E, G, H and N) contained clusters of isolates 
associated with outbreaks in individual countries or regions and three lineages (K, L, and M) 
consisted of isolates having a common root node deriving from strains isolated from the same 
mosquito species (Grobbelaar et al., 2011). 
A more recent study compared sequences from the three mini-genomic segments of viral 
strains from 18 countries across Africa plus Saudi Arabia. In this study, 11 RVFV lineages (A-
K) were identified (Samy et al., 2017). The differences between this phylogeny and the previous 
ones could be the result of a larger dataset. 
 
4. Virus description and genome structure 
RVFV virions, as the majority of Bunyaviruses, are spherical, approximately 100 nm in 
diameter, and are composed of a lipid envelope with glycoprotein spikes (Figure 13). Inside it, 
there are three circular ribonucleoprotein (RNP) complexes comprised of individual genome 
RNA segments associated with the viral nucleoprotein (Maclachlan and Dubovi, 2010; 
Mansfield et al., 2015). 
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Figure 13. Schematic diagram of RVFV structure. The virion is enveloped by glycoproteins and comprises 
three segments (S, M and L) of RNA encoding for structural and nonstructural proteins (Pepin et al., 2010). 
 
The genome of RVFV as all viruses belonging to the Phlebovirus group, is approximately 12 
kb and consists of three segments of negative-sense (or ambisense), single-stranded RNA, 
designated large (L), medium (M), and small (S) (Figure 13). The RNA segments differ in size: 
L RNA segment is of 6.4 kb, the M RNA segment is of 3.2 kb, and the S RNA segment is of 1.7 
kb (Maclachlan and Dubovi, 2010). The L RNA encodes a single large protein L, the RNA-
dependent RNA polymerase (transcriptase). The M RNA encodes a polyprotein that is processed 
to form two glycoproteins (Gn and Gc) and a non-structural protein (NSm). The S RNA, an 
ambisense segment (single-stranded RNA containing both positive-sense and negative-sense 
sequences), encodes the nucleocapsid (N) protein and a non-structural (NSs) proteins 
(Maclachlan and Dubovi, 2010). The N and NSs proteins of RVFV are each translated from a 
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separate subgenomic mRNA. The non-structural NSs protein interferes with the innate host-cell 
antiviral response via inhibition of the cell signaling molecules leading to global suppression of 
the type I interferon response (Maclachlan and Dubovi, 2010; Mansfield et al., 2015). 
RVFV, like other Phleboviruses, is sensitive to heat and acid conditions, and is easily 
inactivated by detergents, lipid solvents, and common disinfectants (Maclachlan and Dubovi, 
2010). 
 
5. Replication 
RVFV, like most Bunyaviruses, replicates in Vero (African green monkey) cells, BHK-21 
(baby hamster kidney) cells, and C6/36 mosquito (Aedes albopictus) cells. 
Viral entry into its host cell occurs by receptor-mediated endocytosis; all subsequent steps 
take place in the cytoplasm. After penetration and uncoating, the virion RNA polymerase 
(transcriptase) is activated and RNA is transcribed to viral mRNAs from each of the three virion 
RNAs (the S, M and L segments) (Maclachlan and Dubovi, 2010). These proteins mature by 
budding into smooth-surfaced vesicles in or near the Golgi apparatus of the host cell to be 
eventually released. 
 
6. Pathogenesis 
Infected people remain mainly asymptomatic; otherwise, the disease begins after a very short 
incubation period (2 to 6 days) with mild fever, severe headache, chills, “back-breaking” 
myalgia, diarrhea, vomiting. Usually the clinical disease lasts 4 to 6 days, followed by a 
prolonged convalescence and complete recovery. In 1% to 2% of affected individuals, the 
disease can become more severe including fulminant hepatitis, encephalitis, retinitis, blindness, 
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or a hemorrhagic syndrome. Among severely affected persons, the case fatality ratio is 
approximately 10% to 20% (Madani et al., 2003). 
Affected cattle, water buffaloes, sheep and goats often remain asymptomatic; but fever 
lasting 24 to 96 hours, dull coat, lacrimation, nasal discharge, excessive salivation, anorexia, 
weakness, bloody diarrhea, low milk yield, and high abortion rates in pregnant cows are common 
symptoms. In ruminant livestock, mortality rate reaches 100% in neonates and 10 to 20% in 
adults (Bird et al., 2009; FAO, 2017). 
 
7. Diagnosis 
RVF epidemics should always be strongly suspected when there is a sudden onset of large 
numbers of abortions in sheep, goats, cattle or camels and deaths in lambs, or calves (Maclachlan 
and Dubovi, 2010). Rapid diagnosis aiming for virus detection is achieved using RT-PCR assays, 
a very sensitive technique able to detect approximately 5 to 10 RNA copies/sample. 
Consequently, it allows for the detection of infection during the early phase of the disease. This 
technique is easily adapted to high-throughput use during epizootics and epidemics but can 
detect viral nucleic acids only during the viremic period, which is relatively transient.  
Moreover, the presence of the virus can be confirmed by virus isolation in cell culture such 
as Vero E6 and BHK-21 cells. The virus is rapidly cytopathic and forms plaques (Maclachlan 
and Dubovi, 2010). In this case, nucleic acid sequencing is used to prove the identity of isolates. 
Virus culture requires high safety level setting and usually conducted in reference laboratories.  
Serologic diagnosis of acute infection is commonly used to seek for the presence of 
immunoglobulin (IgM) capture on sera samples by enzyme immunoassays, neutralization or 
hemagglutination-inhibition assays on sera samples from surviving animals (Maclachlan and 
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Dubovi, 2010).However, the duration of detectable anti-RVF IgM antibody in these animals is 
limited(approximately 60 to 90 days) (Morvan et al., 1992). Tests for detection of total RVF 
virus–speciﬁc immunoglobulins (IgM and IgG) in cattle, sheep, and African buffaloes became 
commercially available (Paweska et al., 2005). Although this assay is unable to differentiate 
acute and convalescent phases of infection, it may be useful in emergency situations. The Virus 
Neutralization Assay is the golden standard assay that is recommended by the World 
Organization for Animal Health (OIE) for international animal trade. But, this technique can 
only be performed in adequate biosecurity facilities. 
 
8. Treatment and vaccine development 
There is no specific treatment for RVF. The most widely tested antiviral agent is the 
nucleoside analogue ribavirin along with its closely related chemical derivatives. However, the 
limited penetration of ribavirin across the blood-brain barrier may limit the effectiveness of this 
treatment in preventing delayed-onset neurologic disease. 
 To date, there is no licensed vaccines against RVF available to immunize humans but 
various strains for livestock and ruminants are licensed and commercially produced such as the 
live-attenuated Smithburn vaccine, Formalin-Inactivated vaccine, and Clone 13 (a form of freeze 
dried live attenuated virus) (Alhaj, 2016). Although, the first two vaccines are widely used in 
control, both of them were accompanied by significant concerns. The first one requires multiple 
doses for protection, causes abortion in pregnant ewes, and has teratogenic effects; and the 
second has a risk of causing abortion and fetal malformation in pregnant animals especially in 
European breeds (Botros et al., 2006). For Clone13 vaccine, it is based on an attenuated strain 
which contains a large deletion in the main virulence factor, the NSs gene (Muller et al., 1995). 
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This strain was shown to be highly immunogenic and experimentally safe. However, intranasal 
inoculation with this attenuated virus has been shown to cause severe neurological disease in 
mice (Dodd et al., 2014), implying that NSs-deleted viruses may still retain some virulence. 
Moreover, the use of this vaccine during the first trimester of gestation remains controversial and 
was associated with malformations and stillbirths (Alhaj, 2016). 
 A newly developed live-attenuated MP-12 vaccine in USA is in clinical trials. It has been 
developed for both animal and humans but was conditionally licensed for animal vaccination 
(Ikegami, 2017). The MP-12 vaccine was developed from the pathogenic ZH548 strain, it is well 
attenuated, and a single dose induces neutralizing antibodies in ruminants (Ikegami, 2017). This 
attenuated viral strain contains mutations in the three viral gene segments (Ikegami, 2017; 
Mansfield et al., 2015).Vaccination trials results have been encouraging with minimal 
teratogenic effects seen in ruminants and suitable immunogenicity in non-human primates 
(Ikegami, 2017). 
Control is based primarily on livestock vaccination, but vector control via the use of 
larvicides and insecticides is also applied during outbreaks to kill mosquitoes. In addition, the 
management the livestock export during RVF epizootic periods is also mandatory. 
 
  
50 
 
Chapter 4 
Vector-virus interactions 
 
Arboviruses are dependent on intricate relationships with their arthropod vectors and 
vertebrate hosts, and these relationships are further shaped by environmental conditions. 
 
1. Vector Capacity and vector competence 
The inter-relationships between viruses, vectors and vertebrate hosts are complex and 
dynamic and shaped by several biotic (viral strain, vector genetics, host susceptibility) and 
abiotic (temperature, rainfall, human land use) factors (Kramer, 2016). 
The Vector Capacity (VC) is the measure of a mosquito population’s capacity to transmit an 
infectious agent to a new susceptible population (Kramer, 2016). This capacity integrates biotic 
and abiotic factors and is quantified by the following formula as reviewed by Kramer (2016): 
VC = [ma2 (I*T) pn]/-ln(p) 
in which: 
 m is the vector density in relation to the host 
 a is the probability that a vector feeds on a host in one day 
 p is the probability that a vector survives one day 
 n is the duration of the extrinsic incubation period (EIP) in days 
 1/-ln(p) is the duration of the vector’s life in days after surviving the EIP 
 I is the infection rate and T is the transmission rate, so I*T represents the vector 
competence. 
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This equation shows that the vector capacity implicitly depends on both, extrinsic factors 
such as the availability of the vertebrate host, its immune status, temperature and rainfall, the 
abundance of vectors; and intrinsic factors like vector survivorship, trophic preferences, the 
blood meal frequency and vector competence. 
Vector competence is one aspect of vector capacity. It defines the ability of the mosquito to 
become infected, replicate and transmit the virus to a host following an infectious blood meal 
(Kramer, 2016). Vector competence is affected also by both extrinsic and intrinsic factors. 
Intrinsic factors include genetic characteristics of both the virus and the vector origins which 
determines the vector's receptivity to the pathogen, and extrinsic factors such as the viral dose 
ingested by the vector and the incubation temperature of vectors after ingestion of an infected 
blood meal (Hardy et al., 1983). 
The study of the receptivity of mosquitoes to different arboviruses has shown that the virus-
vector relationship could be very specific. Different species, subspecies or even populations of 
mosquitoes do not have the same vector competence to the same virus. For instance, Culex 
pipiens mosquitoes, collected from different areas in the Maghreb region, showed diverse viral 
transmission capacities when infected with WNV (Amraoui et al., 2012). Another study showed 
that Culex pipiens biotypes (molestus, pipiens and their hybrid) do not show similar WNV 
transmission rates in the same conditions (Vogels et al., 2016). In the other way around, vector 
competence of one mosquito species is different when tested with different viruses or different 
lineages of the same virus. For example, Culex quinquefasciatus (of the Culex pipiens complex) 
from Florida had different transmission rates with diverse WNV isolates (Richards et al., 2014). 
These observations show that viral and vector genotypes may affect vector competence, but most 
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importantly, the interaction between these two factors shapes the characteristics of viral 
infection, dissemination and transmission. 
As already mentioned, vector competence is influenced, not just by intrinsic factors, but also 
by extrinsic factors such as incubation temperature. In fact, several studies have shown that a 
higher temperature leads to an increase in the rate of infection and a decrease in the extrinsic 
incubation period (EIP). This has been demonstrated for DENV (Watts et al., 1987), the RVFV 
(Brubaker and Turell, 1998), WNV (Dohm and Turell, 2001) and CHIKV (Mourya et al., 2004). 
Experimental observations allow us to notice that the vector competence, in particular viral 
transmission, depends on complex interactions between the three factors: mosquito genotype, 
viral genotype and temperature. It has been demonstrated that some populations of Ae. 
albopictus better transmit some strains of CHIKV at 20°C than at 28°C, whereas this is not the 
case for other populations of Ae. albopictus infected with the same viral strains (Zouache et al., 
2014). This  three-way interaction between mosquito population, virus strain and temperature,  is 
known as genotype-by-genotype-by-environment (G×G×E) interactions (Zouache et al., 2014). 
 
2. Arbovirus transmission by mosquito vectors: mechanism and barriers 
The transmission of an arbovirus by the mosquito vector proceeds in several steps as shown 
in figure 14 (Franz et al., 2015; Hardy et al., 1983; Mellor, 2000). For the transmission to occur 
the vector should first be attracted and feed on a viremic host. The ingested virus within the 
blood meal must then rapidly penetrate into the epithelial cells of the intestine before it is altered 
by the digestive enzymes. Due to specific recognition by interaction of a viral protein with a 
receptor present on the surface of the digestive epithelium, the virus penetrates into the epithelial 
cell by endocytosis and replicates there (Figure 14, steps 1 and 2). After replication, newly 
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formed virions must cross the basal lamina which supports the digestive epithelium and then be 
released into the general cavity of the insect or hemocoel where circulates the hemolymph 
(arthropod circulatory fluid) (Figure 14, step 3). Once the virus has reached the circulatory 
system, it can be disseminated in various tissues and organs such as muscle tissues, nervous 
tissues, fatty body, reproductive organs and salivary glands (Figure 14, step 4). The 
dissemination to the salivary glands allows the excretion of the virus in the saliva and its 
potential transmission during a subsequent blood meal (Figure 14, step 5). Thus, the mosquito's 
gastrointestinal tract and salivary glands appear to be the two main physical barriers to the 
transmission of the virus by a mosquito (Franz et al., 2015). 
 
 
Figure 14. Steps of virus dissemination in the mosquito vector: 1. Ingestion of an infectious blood meal. 2. 
Viral replication and passage in the midgut cells. 3. Virions pass in the hemocoel. 4. The virus infects 
secondary organs such as salivary glands. 5. The virus is secreted in saliva and other hosts may be infected. 
Adapted from AIV, IP. 
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It is largely known that the mosquito defense system is unable to clear arboviral infections 
but can effectively limit viral dissemination to a tolerable level (by the mosquito).  This requires 
a complex interaction between the mosquito immune system and viruses which makes 
mosquitoes an ideal vector for virus transmission without being seriously affected. 
The mosquito gut is the first-line barrier to limit viral dissemination. Studies conducted on 
Ae. aegypti suggest the existence of several pathways to restrict infections by arboviruses, 
including Flaviviruses: the RNA interference (RNAi) pathway, the Toll pathway, and the JAK–
STAT pathway. Moreover, the gut microbial flora is also considered an important factor to 
control the midgut viral infection (Cheng et al., 2016). 
In the hemocoel, the virus is immersed in a nutrient-rich environment that contains immune 
cells (innate cellular responses) and humoral response factors produced by hemocytes pericardial 
cells and fatty substances. Although mosquito hemocytes are permissive for the replication of 
arboviruses, humoral immunity in the hemolymph playsan important role in limiting systemic 
dissemination of these arboviruses (Xiao et al., 2014). The humoral components refer to soluble 
molecules in hemolymph such as pattern recognition receptors, antimicrobial peptides, and 
components of the phenoloxidase (PO) cascade that leads to the formation of melanin (Cheng et 
al., 2016; Hillyer, 2010). The role of melanization in eliminating bacterial and parasitic 
infections in invertebrates is relatively well elucidated. However, the antiviral role of 
melanization is poorly understood. 
The salivary glands are apparently permissive for arboviral replication (Vega Rua, 2015). 
Nevertheless, recent studies revealed that, at this level, immune reactions that limit viral 
replication do exist (reviewed in (Cheng et al., 2016). The salivary peptide cecropin (CEC) like 
(an antibacterial peptide) has been suggested to have a potent anti-DENV and anti-CHIKV 
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activity. This antiviral activity was validated in an in vitro cell culture system (Luplertlop et al., 
2011) and reviewed in (Cheng et al., 2016)). The virus present in the salivary glands ensures 
horizontal transmission to a new vertebrate host by the saliva emitted by infected females (Hardy 
et al., 1983). 
In some cases, the virus can disseminate to mosquito’s reproductive organs. The presence of 
the virus in the ovaries and eggs can promote its vertical transmission (vertical transmission: 
from infected females to eggs). This rare phenomenon allows some arboviruses to persist in the 
absence of receptive hosts and during dry or cold periods, or during the absence or low density of 
mosquitoes that adversely affects horizontal transmission (Dohm and Turell, 2001; Dohm et al., 
2002; Lequime and Lambrechts, 2014). 
Viral infection is generally persistent in females. Therefore, once infected, the mosquito will 
be able to transmit the virus throughout its life. The time between the ingestion of the infectious 
meal and the time the mosquito becomes capable of transmitting the virus present in the saliva 
corresponds to the extrinsic incubation period (EIP) (Hardy et al., 1983). EIP varies according to 
the dose of virus infected in the mosquito, the viral genotype, the vector genotype, and external 
factors such as larval nutrition and temperature (Hardy et al., 1983). For effective transmission of 
a pathogen, the EIP must be shorter than the life of the vector. Thus, EIP is a key parameter of 
viral transmission. 
 
3. Vector competence assessment 
As previously noted, the determination of vector competence is essential for evaluating the 
potential for transmission of arboviruses by vectors. The vector competence is unique and 
characteristic of each mosquito-virus combination. Indeed, the evaluation of vector competence 
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makes it possible to predict the epidemiological risks posed by the introduction of an arbovirus 
in a certain environment where the populations of local mosquitoes can present a good 
receptivity to the viral infection (Hardy et al., 1983; Kramer and Ciota, 2015). This helps to 
identify localities in need of strengthening epidemiological surveillance (control and isolation of 
imported cases). 
The evaluation of vector competence is carried out in the laboratory using experimental 
infections. Mosquitoes of the species and population of interest are raised under controlled 
conditions of nutrients, temperature, humidity and photoperiod. Females are starved 48 hours 
before being fed on an infectious mixture containing fresh rabbit blood and a viral suspension of 
known titer is prepared. Fully engorged females are kept for analysis. The viral dynamic within 
these females is monitored at different days during the post-infection incubation period (pi) in 
order to assess the vector competence. In this perspective, the following parameters are usually 
evaluated at all kinetic points: 
 Midgut infection rate: proportion of mosquito females with infected midgut among tested 
ones (alive and engorged at Day 0) 
 Disseminated infection rate: proportion of females with infected head or legs or wings 
among females with infected midgut. 
 Dissemination efficiency: proportion of mosquito females with infected head or legs or 
wings among tested ones. 
 Transmission rate: proportion of females with infectious saliva among females able to 
disseminate the virus beyond the midgut barrier (with infected head or legs or wings). 
 Transmission efficiency: proportion of mosquito females with infectious saliva among 
tested ones. 
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Thus, the disseminated infection rate and the dissemination efficiency allow the evaluation of 
the ability of the virus to cross the midgut barrier of the mosquito and to disseminate to other 
internal organs/tissues. While the transmission rate and the transmission efficiency indicate the 
capacity of the virus to cross the ultimate barrier of the salivary glands to be released into the 
saliva of the mosquito. Therefore, transmission rate and efficiency are the main parameters for 
assessing the epidemic risk associated with the transmission of a given virus by local 
mosquitoes. 
To estimate the rate and efficiency of transmission, mosquito saliva should be recovered by 
forced salivation technique (Dubrulle et al., 2009). Briefly, after removing the legs and wings of 
the female mosquito, the proboscis is inserted gently into a tip containing Fetal Bovine Serum 
(FBS) and the mosquito is left to salivate for 30-45 minutes (Figure 15). The infectious status 
and the number of infectious viral particles in collected saliva are determined by viral titration on 
insect (C6/36) or mammalian (Vero) cells. 
 
 
Figure 15. Forced salivation technique. After removing the legs and wings of the female mosquito, the 
proboscis is inserted gently into a tip containing Fetal Bovine Serum. 
  
58 
 
Chapter 5 
Study Objectives 
 
During this PhD research project, we aimed to assess the circulation of WNV in Lebanon and 
the capacity of local strains of Cx. pipiens to transmit, under experimental conditions, WNV and 
RVFV. Therefore, our project was divided into two parts: 
The first part covers the epidemiology of WNV in Lebanon and aims to provide evidence of 
WNV circulation by screening mosquito populations for WNV RNA and by detecting WNV 
specific antibodies among human, horses and chicken sample populations. This was achieved by: 
 Collecting mosquitoes from two different geographical areas in the country: the Bekaa 
Valley and North Lebanon. Collected samples were: 
- Morphologically identified using specific keys. 
- Screened for WNV RNA by molecular analysis (RNA extraction and RT-PCR) 
on identified mosquito pools. 
 Collecting blood samples from human residents, horses and chicken in different areas in 
the country. The collected sera were then analyzed by serological techniques as follows: 
- Detection of IgG or IgY antibodies against WNV by in-house ELISA. 
- Confirmation of ELISA positive sera by PRNT and estimating the circulation rate 
of the virus among each population. 
- Observation of potential seroconversion in sentinel chickens in order to assess 
potential current WNV circulation. This was performed by detecting specific IgY 
level increase in these sentinels during the transmission season. 
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The second part of this study aimed to assess the vector competence of local populations of 
Cx. pipiens against both WNV and RVFV. For this, the following activities were performed: 
 Culex pipiens egg rafts were collected. 
 Mosquitoes were reared and maintained in BSL3 facilities. 
 Females of Cx. pipiens were artificially fed with blood infected with WNV or RVFV. 
 Estimation of viral infection, dissemination and transmission rates at different days after 
experimental infection with each virus. 
 The vector competence of both Cx. pipiens biotypes was compared in order to detect any 
genetic influence on the virus transmission. 
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Part 2 
Empirical Studies  
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Chapter 6 
Survey of West Nile Virus in Lebanon 
 
Introduction 
 
WNF is an arboviral infection caused by a flavivirus that is transmitted from infected birds to 
humans by the bite of a broad range of mosquito species, but mainly members of the Culex 
genus. WNV infects mostly birds which constitute the main reservoir. Humans, just like horses, 
are “dead-end” hosts, meaning that they might be infected but do not spread the virus. The 
infection is usually asymptomatic in humans. WNV infections have been reported in many 
tropical and temperate countries in Africa, Europe, Asia, America and the Middle East. Recent 
outbreaks have affected Palestine in 2000, Greece in 2010 and 2011, and Turkey in 2010. In 
addition, evidence of virus circulation has been reported from Jordan and Egypt. 
In Lebanon, human and animal cases caused by WNV have never yet been reported. 
However, we suspect the existence of this disease in the country. The introduction of this virus is 
likely to occur through the migratory birds that usually cross Lebanon during the migration 
season. Besides, Culex pipiens, the primary vector, is widespread in the country.  This species is 
established in the coastal zone in addition to inland locations where the stagnant water systems 
are scattered. During this research project, we assessed the circulation of WNV in Lebanon by 
screening mosquito populations for this virus and by detecting specific antibodies among human, 
horse and chicken populations. 
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Material and Methods 
 
1. Geographical description of Lebanon 
Lebanon is a mountainous country located on the eastern side of the Mediterranean Sea. It is 
characterized by a typical Mediterranean climate. The landscape of the country is characterized 
by parallel alternation of plains and high lands creating four longitudinal geographic regions 
(Figure 16). 
 
 
Figure 16. Lebanon landscape map. 
 
The first region is a narrow coastal strip that becomes relatively broader at the Northern part 
of the country near Tripoli. This region is heavily urbanized and contains the major cities. The 
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agricultural life is limited to the north and the south of the country in which Citrus trees are 
planted. During the summer, and specially July and August, the weather is hot and steamy, and 
humidity can reach 90%, with temperatures over 30°C. The rain falls are mainly from December 
to March with relatively cold weather. 
The second region is formed by the Mount Lebanon chain, running parallel to the coastline, 
and peaking at the northern part at 3083m. It has a typically Alpine climate with important 
snowfall and temperatures below zero on the mountains during winter. 
The third region is the Bekaa plain, which is considered part of the Great Rift Valley that 
extents until South East Africa. It is an inland plain, situated 1000m above sea level. The 
northern part of this plain is arid with an average rainfall. The Bekaa Valley is shielded from the 
influence of the sea by the Lebanon Mountains. Therefore, the Bekaa is drier than the rest of the 
country with considerably less precipitation not exceeding 100 mm in its upper part (Hermel 
district) and a wider variation in daily and yearly temperatures. Summers are hot and dry, while 
winters are cold and frosty. It is a fertile and farming region in which two rivers originate: the 
Orontes River in the Northern district of Hermel and the Litani River that crosses the West 
Bekaa region. Moreover, the Bekaa region is relatively rich in stagnant water plans such as the 
Qaraoun artificial lake and Aammik natural swamps which provide a favorable environment for 
the breeding and proliferation of mosquitoes. Besides, this region is considered an important 
stopover for migratory birds (Figure 17). 
The fourth region is formed by the Anti Lebanon Mountains that form the natural eastern 
border with Syria. The range's highest peak is Mount Hermon at 2814m. 
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Figure 17. Flyways of migratory birds. 
 
2. Entomological study part 
a. Mosquito collections and processing 
Adult mosquito specimens were collected during August and September 2014 from seven 
villages: 4 in the semi-arid district of West Bekaa, West of Lebanon, and 3 in Akkar district, a 
humid area North of the country (Figure 18). 
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Figure 18. Collection sites of mosquitoes, humans, horses and chicken blood samples. 
 
Collections were performed using two types of traps: CDC (Centers for Disease Control) 
light trap (Florida, USA), fitted or not with a CO2 source (Figure 19A), and BG-sentinel traps 
(Biogents ®)  using Bg-lure attractant containing lactic acid, ammonia and fatty acids, 
substances usually found on the human skin (Figure 19B). Traps were placed outdoor (mainly 
houses backyards) and in animal shelters (cattle and horses) from sunset till the next morning. 
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Collection bags were chilled in a freezer for one hour, mosquito specimens were then separated 
from other insects, placed in labeled cryotubes and stored in liquid nitrogen. Back to the 
laboratory, collection tubes were stored at -80°C until use. 
 
 
Figure 19. A. CDC light trap (BioQuip Products, 2011). B. BG sentinel trap (Biogents Products, 2017). 
 
b. Mosquito identification 
Mosquito specimens were identified under a stereomicroscope and placed in tubes containing 
RNA stabilizing solution (MCLAB, USA). The morphological identification was performed 
using a key for Mediterranean mosquitoes (Dubose and Curtin, 1965) in addition to the 
following digital identification keysμ “The Mosquitoes of Europe” (IRD, 2001) and “The 
mosquitoes of the Mediterranean Africa” (IRD, 1999). Identified mosquitoes were pooled 
according to collection location, gender and species. Each pool contained up to 25 specimens. 
Mosquito pools were then preserved at -80°C for subsequent molecular analysis. 
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3. Screening for vector infection 
Total RNA extraction followed by standard Reverse Transcription Polymerase Chain 
Reaction (RT-PCR) was performed on mosquito pools using WNV specific primers targeting the 
NS5 viral gene. 
 
a. RNA extraction 
RNA stabilizing solution was removed from the tubes, in which mosquitoes were pooled, 
before any manipulation. Total RNA was extracted using the NucleoSpin RNA isolation kit 
(Macherey-Nagel, Germany). Following the manufacturer’s protocol, a first step of 
homogenization of the tissues was done by using the kit’s Lysis Solution/2-Mercaptoethanol 
mixture that is required to fully inactivate RNases. Two sterile stainless steel beads (5mm 
diameter, Qiagen, USA) were added to each tube and tissues were grinded and crushed by vortex 
until no visible debris was observed (around two minutes). Note that after homogenization, two 
centrifugations were performed on supernatants of homogenates in order to get rid of mosquito 
debris that may block the filter/column during the RNA extraction process. After 
homogenization, proteinase K (Qiagen, USA) was added to the homogenate and incubated at 
55°C for 10 min to effectively release RNA from fibrous tissues. RNA extraction process 
continued as per the manufacturer’s protocol. RNA was collected and stored at -80°C. A dosage 
of the RNA products was performed using the NanoDrop Lite Spectrophotometer (Thermo 
Scientific, USA). This quantification was used to determine the volume of RNA extract needed 
for the reverse transcription (RT) step. 
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b. Reverse transcription 
Subsequent to RNA dosage, the GeneAmp Gold RNA PCR Reagent Kit (Applied 
Biosystems, USA) was used to obtain a cDNA and perform a PCR. A Two-Step RNA PCR was 
done in order to keep the cDNA for any further studies. As per the manufacturer’s protocol, in 
the Reverse Transcription (RT) step, 5µL RNA samples or templates of the mosquitoes’ RNA 
pools, the positive control RNA (pAW109 RNA) provided by the kit and the negative control or 
blank were transcribed. This reverse transcription reaction was performed using the GeneAmp 
PCR System 9700, Applied Biosystems, Thermal Cycler (USA). Then the cDNA products were 
conserved at -20°C. 
 
c. PCR amplification and viral characterization 
The PCR mix was prepared using the Thermo Scientific (USA) PCR master mix kit. Specific 
selected WNV desalted primers (Integrated DNA Technologies IDT, USA) WNV NS5 WN 9794 
and WNV NS5 WN 9483 were used to screen the pools for WNV RNA (Kauffman et al., 2016; 
Lanciotti et al., 2000). These primers amplify a 326 base pairs (bp) fragment within the Non 
Structural protein (NS5) gene which encodes for the viral RNA-dependent RNA polymerase 
(Lanciotti et al., 1999). This polymerase is the most highly conserved protein of WNV (and of 
Flaviviruses in general) (Brinton, 2002). As a consequence of the conserved nature of the region, 
chosen primers should readily bind to any potential strain of WNV. The sequences of the used 
primers are shown in table 2. In addition, Primer DM151 and Primer DM152, upstream and 
downstream respectively, were used to amplify the positive control gene (pAW109 RNA) for the 
reverse transcriptase reaction. 
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Table 2. WNV NS5 primer sequences (Kauffman et al., 2016; Lanciotti et al., 2000). 
Description Sequence (5'-3') Size bp 
WN 9483 CAC-CTA-CGC-CCT-AAA-CAC-TTT-CAC-C 326 WN 9794 GGA-ACC-TGC-TGC-CAA-TCA-TAC-CAT-C 
 
Primers were used at a final concentration of 0.5µM in a reaction volume of 50µL PCR 
mixture. 3µL cDNA was used for amplification. After optimization, PCR cycling parameters 
were as follows: Enzyme activation at 95°C for 10 min, PCR (denaturation, annealing, 
extension) with 35 cycles at 94°C for 45 s, 56°C for 45 s, 72°C for 1 min, PCR final step 
(elongation) at 72°C for 10 min. This amplification reaction was performed using the GeneAmp 
PCR System 9700, Applied Biosystems, Thermal Cycler (USA). WNV cDNA positive control 
was generously provided by Dr. Laura Kramer (Laboratory of Arboviruses, Slingerlands, New 
York, USA). 
The obtained PCR products were run on a 1.5% agarose gel electrophoresis suspended in 
Tris Borate EDTA (1×TBE) running buffer (Appendix E: 10×TBE buffer Preparation). DNA 
fragments were colored by Gel Red Nucleic acid gel stain (Biotium, USA). Potential WNV 
amplicons are expected to appear at 326 bp position. 
DNA purification was performed using the NucleoSpin Gel and PCR Clean-up kit 
(Macherey-Nagel, Germany). According to the manufacturer’s protocol, the band of interest was 
cut from the gel and prepared in order to bind DNA on a silica membrane within the spin 
column. The eluted DNA was ready for immediate use or stored at -20°C. Purified DNA samples 
were submitted to sequencing using the same PCR primers. The obtained sequences were 
identified after their alignment with sequences of different strains published in GenBank. 
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4. Blood samples collection 
The serological study was conducted on three types of hosts: humans, horses and chickens. 
Blood samples were collected in 5mL gel tubes. Human blood samples were all collected by 
certified laboratory technicians whereas horse and chicken blood samples, they were withdrawn 
by veterinarians. 
 
a. Human blood collection 
Two human populations were included in this seroprevalence study. The first population 
consisted of consenting donors from the Bekaa region, an area characterized by the presence of 
large water systems. All involved participants were outpatients attending the laboratories of three 
hospitals in the study area in order to conduct routine blood analysis: Tal Chiha Hospital in Zahle 
(June 2013), Bekaa Hospital in Taanayel, Chtoura (June-September 2013) and Farhat Hospital in 
Kamed El Lawz (July and August 2013) (Figure 18). 
The sera of the second population were taken from a serum bank and belong to patients that 
were involved in a previous serosurvey on Sand fly fever virus. All patients were recruited in 
September 2012 from outpatients attending two laboratory facilities in North Lebanon district: 
the laboratory of health dispensary of the United Nations Relief and Works Agency (UNRWA) 
inside Nahr El Bared Camp (NBC) for Palestinian refugees in Akkar and the laboratory of the 
military clinic in Al Kobbeh, Tripoli, North Lebanon (Figure 18). 
All participants have signed a consent form and filled a questionnaire in Arabic language 
(Appendices A and B). Translated versions of both forms appear in Appendices C and D. The 
consent form notified each participant about the objectives of the study, the requirements and the 
confidentiality of results. The questionnaire aimed to collect information about the participant’s 
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socio-economical factors (gender, place of residence, work nature, summer fever history, travel 
history…). Only patients below λ and above 85 years old were excluded from this study.  
 
b. Horse blood collection 
Equine sera samples for the seroprevalence study part were collected from June to October 
2015 from farms and riding clubs in rural areas of the following districts in Lebanon: Tripoli, 
Akkar, Baalbeck, Hermel, Zahle, West Bekaa, Nabatiye, Saida and Jezzine districts (Figure 18). 
Most of the collected samples belonged to horses but some were from ponies; the horses were of 
diverse age, breed and gender.  
Blood was obtained from the jugular vein (Figure 20). Horses were checked for microchips 
using a microchip scanner. ID numbers, horse’s name, age, gender, breed and medical history 
were registered, when available. None of the horses or ponies being tested has been vaccinated 
against WNV. Some farms and clubs employed pest control measurements on the horses and in 
the facility. 
 
 
Figure 20. Blood withdrawal from the jugular vein of a horse (The Courier Journal, 2015). 
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c. Chicken blood collection 
In order to estimate the seroprevalence of WNV, blood samples were collected from egg-
laying hens that were raised in gardens of private houses in different villages of the Bekaa Plain. 
Blood collection was performed between September and December 2015. Samples were 
collected from 15 different locations in West Bekaa, Zahle, and Baalbek districts (Figure 18). 
Moreover, and in order to assess the current circulation of WNV in the Bekaa area, a 
seroconversion study was conducted. Therefore, two groups of ten sentinel chickens each were 
placed in Younine (Baalbek) and El Marj (West Bekaa) villages (Figure 18). In each locality, 
five white and five red chickens (Leghorn) were marked with wing nodes made by ribbons of 
five different colors. These chickens were entrusted to a villager in each locality who placed 
them in his private garden (outdoor) during the study period. Blood samples were withdrawn 
from each of these chickens: one in September 2015 (coinciding with the beginning of bird 
migration period), one in October 2015 and the last one in December 2015. The aim of this study 
is to detect the appearance of specific antibodies against WNV in these chickens and to monitor 
their evolution over time. All Chicken blood samples were collected from the alary vein (Figure 
21). 
 
 
Figure 21. Blood withdrawal from the alary vein of a chicken. 
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5. Sera screening by ELISA 
After blood collection, all samples of different origins were brought to the laboratory and 
centrifuged at 4000g for 10 min in order to obtain the sera. Aliquots from each serum were 
prepared under sterile conditions and stored at -20°C for further use. 
All collected sera were tested for the presence of specific antibodies against WNV: IgG 
antibodies (in human and equine) and IgY antibodies (in chicken). The technique used was an in-
house indirect Enzyme Linked Immunosorbent Assay (ELISA) based on the protocol performed 
at the Laboratory of Arboviruses (Slingerlands, New York State Department of Health, USA). A 
series of optimization tests were done to determine Coating Antigens’ concentrations, secondary 
antibody dilutions, and buffers to be used in the laboratory conditions. 
The coating antigens consisted of a normal slurry antigen (also called negative antigen) and 
another positive WNV antigen. The first is composed of the lysate of uninfected Vero cell 
culture. The latter consisted of the lysate of WNV (New York 1999 strain) cultured on Vero cell. 
Both antigens in addition the required human and horse positive and negative controls were 
generously provided by Dr. Laura Kramer’s Laboratory. Chicken positive and negative controls 
were kindly provided by Dr. Sylvie Lecollinet from Maison Alford, Paris, France. All used 
controls belonged to sera confirmed positive or negative against WNV by PRNT. 
The applied ELISA protocol was similar for human, equine and chicken sera. Briefly, 50µL 
of antigen diluted at 1:200 in fresh coating buffer (Appendix E: Coating buffer preparation) were 
applied to each 96 wells of Nunc-Immuno MicroWell ELISA plates (Sigma, USA). The normal 
slurry antigen was dispensed in the wells of the 1st, 4th, 7th and 10th columns while the positive 
antigen was distributed in the wells of the remaining columns of the plate (Appendix F: plate 
plan). The antigens were allowed to bind during an overnight incubation at 4°C. 
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The following day, the coat solution was discarded, the plate was washed three times with 
Phosphate Buffered Saline (1×PBS) 0.05% Tween 20 (PBS-T) (Appendix E: 10XPBS buffer 
preparation). 100ȝL blocking buffer (5% skimmed milk in PBS-T) was added, and the plates 
were left in a humid chamber at 37°C for 1 hour. Following incubation, blocking solution was 
discarded and plates were washed as above. 50ȝL of each serum sample, diluted 1μ200 in PBS-T-
BA buffer (1×PBS, 0.05% Tween 20, 0.5% Bovine Serum Albumin (BSA)), were dispensed to 
one negative and two positive antigen-containing wells. Plates were then returned to a humid 
chamber and incubated at 37°C for 1 h. 
Afterward, plates were removed, washed as above, and 50ȝL of goat anti-human IgG (H+L) 
Horseradish Peroxidase (HRP) secondary antibody (Southern Biotech, USA), diluted 1:4000 in 
PBS-T-BA buffer, were added to each well. For horse and chicken sera screening, goat anti-
equine IgG (H+L) HRP (Southern Biotech, USA) or goat anti-chicken IgY (H+L) HRP 
(Southern Biotech, USA) were respectively used at the same dilution. After incubation and 
washing as above, potentially formed immune complexes were revealed by the addition of 50ȝL 
of 3,3’,5,5’-Tetramethylbenzidine (TMB) liquid substrate (Eurobio, France) for 10 min. The 
reactions were stopped with 50ȝL of 1μ20 HCl, and the optical density (OD) of each well was 
read at 450 nm (Ȝread = 450 nm and Ȝreference = 4λ2 nm) using ELISA reader Multiskan FC 
(Thermo Scientific, USA). It is worth noting that in each plate, in addition to the control sera 
samples, blank (wells without serum and secondary antibodies) and secondary antibodies (wells 
without serum) controls were designated. For each serum, a ratio of OD obtained on the positive 
antigen (ODP) over the OD obtained on the negative antigen (ODN) was calculated. We 
considered a human serum as positive for WNV when the value of ODP/ODN was greater than 
or equal to 2. Whereas for horse and chicken sera samples, we considered suspected positive all 
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sera showing an ODP/ODN ratio greater than 1.2. These ratio cut-off values were chosen 
according to the number of tested sera samples, in a way not to miss any potential positive 
sample. 
Some validation criteria were taken into consideration to validate observed results in each 
plate. These criteria depended mainly on the OD values of the positive and negative control sera, 
the secondary antibody and blank controls. 
 
6. Confirmation by PRNT 
The plaque-reduction neutralization test (PRNT) is considered the gold standard procedure to 
confirm arboviral infection especially when other serological techniques, such as ELISA and 
Immunofuluorescence Assay (IFA), show important cross reactivity between closely related 
circulating viruses (in our case, other flaviviruses). PRNT is used to determine the titer of 
neutralizing antibodies for a virus in a serum sample. The assay is time consuming and laborious. 
For this reason, it is mainly performed in reference laboratories and in high security level 
settings. 
All sera that turned to be positive for WNV by ELISA (at the fixed threshold), were tested by 
PRNT for confirmation at the Laboratory of  Arboviruses (Wadsworth Center, New York State 
Department of Health, Slingerlands, New York, USA) as part of a scientific collaboration project 
with our  laboratory (Laboratory of Immunology and Vector-Borne Diseases, Faculty of Public 
Health, Lebanese University). Here, we take this opportunity to thank Dr. Laura Kramer, head of 
the American partner laboratory, for her generous collaboration and precious advices that guided 
our project. 
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Fresh Vero cell suspension (2.0×105 cells/mL) is prepared and dispensed (3 mL/well) in 6 
well plates. Plates are then incubated at 37oC and 5% CO2. Test sera were serially diluted from 
1:5 through 1:160 in BA-1 diluent (Medium-199H, 0.05M Tris pH 7.6, 1% bovine serum 
albumin, 0.35g/L sodium bicarbonate, 100 units/mL penicillin, 100 µg/ mL streptomycin, and 1 
µg/mL fungizone) in a 96-well plate (100 µL/well). The WNV (strain NY-1999) was diluted to 
obtain 200 PFU/100µL. Afterward, the viral suspension was distributed on the plate wells and 
mixed with the existing 100µL of diluted sera. The plate was then incubated overnight at 4°C. 
The following day, 100µL of each serum-virus mixture was added onto confluent 
monolayers of Vero cells (in the 6 well plates) and allowed to adsorb at 37oC for 1 h, after which 
an agarose overlay (3 mL/well) was added and incubation was continued. When virus plaques 
became visible, a second overlay of nutrient-agar (3 mL/well) containing Neutral Red (1mL of 
Neutral Red/100 mL of overlay) was added. Neutral red stains viable cells leaving white/cleared 
plaques where virus is present. The plates are then returned to the incubators. 
In order to determine the neutralizing titer, a virus control (also called back-titration) was 
prepared. It consists of duplicate virus suspensions containing 200, 20, and 2 PFU/0.1 mL mixed 
with an equal volume of BA-1 diluent to contain 100, 10 and 1 PFU/0.1 mL. 
 Plaques were counted on the 3rd (WNV) day after the viral inoculation. The highest dilution 
of serum neutralizing 90% of the inoculum as determined by back-titration (control) was 
considered the neutralizing titer. WNV positive and negative control sera were used in this test. 
 
7. Statistical analysis 
All human serological results were statistically analyzed in terms of frequencies and 
percentages. For each qualitative variable, seropositivity against WNV, human participant 
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gender, place of residence and presence of domestic animals, frequencies and percentages were 
calculated. The chi-square test was used to compare the frequencies and percentages between 
groups of each qualitative variable. Fisher’s exact test was used when indicated. Statistical 
Package for the Social Sciences (SPSS) software version 16.0 was used for the analysis of 
obtained data. 
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Results 
 
1. Description of mosquito collections 
Adult mosquito trapping in West Bekaa (Jebb Jennine, Qaraoun, Ein El Jawzi and El Marj 
villages), over the period of 6 days, yielded 2934 adult mosquitoes with a total of 78 trap-days. 
Identification of these specimens showed that 91.65% of collected mosquitoes were Culex 
pipiens. The remaining specimens (8.35%) belonged to four other species: Culex martini, Culex 
perexiguus, Culiseta longiareolata and Orthopodomyia pulcripalpis (Table 3). 
Adult mosquito trapping in Aakar, North Lebanon, in three different locations, using CDC 
light traps and BG sentinel traps, over the period of 15 days, yielded 3912 adult mosquitoes with 
a total of 88 trap-days. Identification of these specimens showed that 83.90% of collected 
mosquitoes were Culex pipiens. In addition, other species were found in much lower percentages 
such as, Culex martini, Culex perexiguus and Culiseta longiareolata (Table 4). 
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Table 3. Species composition and description of collected mosquitoes in localities of West Bekaa during August 2014. 
Place 
Coordinates Altitude 
(m) 
# of 
collection 
days 
Trap 
type 
Trap-
days 
Culex 
pipiens 
Culex 
perexiguus 
Culex 
martini 
Culiseta 
longiareolata 
Orthopodomyia 
pulcripalpis Incompl
ete 
LAT LONG F M F M F M F M F M 
Jebb 
Jenni
ne 
33°37'
58" N 
35°46'
55" E 870 3 
BG 
sentinel 8 27 58   2  3 3  2 4 
CDC 19 360 33 7  18  1 2  2 37 
El 
Marj 
33°45'
42" N 
35°53'
10" E 870 2 
BG 
sentinel 8 119 256     3 5  1 11 
CDC 19 1042 11 2  5 2 4 1  4 53 
Qarao
un 
33°34'
10" N 
35°43'
10" E 900 2 
BG 
sentinel 6 37 73   3  4 2  1 7 
CDC 13 658 9 1  2  2 6   41 
Deir 
Ein El 
Jawzi 
33°35'
49" N 
35°41'
29" E 1000 1 
BG 
sentinel 2 1        2 2  
CDC 3 5           
Total 78 2249 440 10 0 30 2 17 19 2 12 153 
Total of specimens (%) 2689 (91.65%) 10 (0.34%) 
32 
(1.09%) 36 (1.23%) 14 (0.48%) 
153 
(5.21%) 
Grand total 2934 
LAT: Latitude, LONG: Longitude, #: number, F: female, M: male 
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Table 4. Species composition and description of collected mosquitoes in localities of North Lebanon during September 2014. 
Place 
Coordinates Altitude 
(m) 
# of 
collection 
days 
Trap 
type 
Trap-
days 
Culex 
pipiens 
Culex 
perexiguus 
Culex 
martini 
Culiseta 
longiareolata Incomplete 
LAT LONG F M F M F M F M 
Darine 34°36'15" N 
36°06'
25" E 74 1 
BG 
sentinel 2 22 11       6 
Klayaat 34°35'10" N 
35°59'
35" E 5 2 CDC 12 1    1     
El 
Bahsa 
Bebnine 
34°30'
90" N 
35°59'
25" E 70 12 CDC 74 2748 500 82  8  12  521 
Total 88 2771 511 82 0 9 0 12 0 527 
Total of specimens (%) 3282 (83.90%) 82 (2.10%) 
9 
(0.23%) 12 (0.31%) 
527 
(13.47%) 
Grand total 3912 
LAT: Latitude, LONG: Longitude, #: number, F: female, M: male 
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2. Molecular screening of mosquitoes for WNV 
Collected mosquito specimens were separated into pools according to collection site, species 
identity and gender. Mosquitoes collected from West Bekaa were divided into 66 pools, each 
contained up to 50 mosquitoes. Fifty seven of them were composed of females Cx. pipiens as 
shown in Appendix G. Similarly, mosquitoes collected in Aakar were divided into 141 pools. 
Each pool contained up to 25 mosquitoes; 119 of these pools were composed of females Cx. 
pipiens (Appendix G). Following DNA extraction, each pool was screened for the presence of 
WNV gene by a 2-steps RT-PCR. Screening results showed that all tested pools were negative 
for WNV (Figure 22). 
 
 
Figure 22. Gel electrophoresis picture of PCR products. Wells from left to right represent: DNA ladder, 
reverse transcription positive control band on 308 bp, reverse transcription negative control, WNV positive 
control band of 326 bp, PCR negative control, pools # 1 to 5 all negative for WNV. 
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3. Serological study of human population 
a. Description of participants 
For this study, we analyzed 803 serum samples of consenting outpatients attending 
laboratory facilities of three hospitals in West Bekaa: 168 from Tal Chiha Hospital in Zahle, 501 
from Bekaa Hospital in Taanayel-Chtoura and 134 from Farhat Hospital in Kamed El Lawz. In 
addition, in Northern Lebanon, a total of 288 sera were collected from consenting participants 
recruited equally in the UNRWA dispensary at Nahr El Bared Camp, Akkar and in the laboratory 
of the military clinic of El Kobbeh Army Barrack, Tripoli (Table 5). 
 
Table 5. Description of human sample population. 
Area Location Sample population (N) Females Males Median Age 
Bekaa 
Bekaa Hospital 501 298 203 36 
Tel Chiha Hospital 168 97 71 49 
Farhat Hospital 134 89 45 31 
Bekaa total 803 484 319 39 
Akkar Nahr El Bared Camp 144 106 38 37.5 
Tripoli El Kobbeh Barrack 144 101 43 40.5 
North total 288 207 81 40 
Cumulative total 1091 691 400 39 
 
Almost two third of the participants were females (63.34%) (Table 5). The age range of the 
population was between 9 and 85 years with an average age of 40.7, a median of 39, and a high 
representation of participants aging between 21 and 30 years old (Figure 23). Their occupations 
varied from indoor and outdoor types of jobs, to soldiers or students (Figure 24). Moreover, 499 
female participants (72.21%) were either house wives or unemployed; and 97 male participants 
(24.25%) were either unemployed or retired. 143 male participants had outdoor jobs such as in 
agriculture, farms, construction or drivers or several other occupations. 104 male participants had 
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indoor or desk jobs in banks, administration of companies, or hospital staff or other occupations. 
The remaining participants were soldiers and students (Figure 24). 
 
 
Figure 23. Bar chart representing the age distribution of the study participants. 
 
 
 
Figure 24. Bar chart showing the profession distribution of the study participants. 
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b. Seroprevalence results 
Sera analysis using an in-house ELISA technique was performed on all collected samples, 
and those showing an OD ratio above 2 were considered as suspected positive. Results revealed 
that 74 individuals (9.22%, N=803) from Bekaa region and 2 participants (0.69%, N=288) from 
North area were seropositive against WNV (Figures 25 and 26). This brings the seroprevalence 
rate for both regions to 6.97% (76 sera out of 1091). 
 
 
Figure 25. Scatter graph showing OD ratio obtained by ELISA on human sera samples collected from Bekaa 
region. The red line represents the fixed threshold (OD ratio = 2). 
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Figure 26. Scatter graph showing OD ratio obtained by ELISA on human sera samples collected from North 
Lebanon. The red line represents the fixed threshold (OD ratio = 2). 
 
In order to confirm seropositivity after ELISA, PRNT was performed on suspected sera (OD 
ratio ≥2). Nevertheless, for the North area, and since the number of suspected positive samples is 
limited (only 2), we included in the seroneutralization test those sera having OD ratio ≥ 1.7 in 
order to avoid missing any potential positive specimen (Figure 26). Results showed that only 11 
samples from the Bekaa region had neutralizing antibodies at a titer of 40 or higher whereas no 
sera from North Lebanon had WNV specific neutralizing antibodies at the fixed titer. This brings 
the seroprevalence rate of WNV to 1.37% in the Bekaa area and 0% in North Lebanon area 
(1.01% in both regions together). It is worth noting that three and four samples, from Bekaa and 
North regions respectively, had neutralizing antibodies at a titer of 20 or below (Table 6). 
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Table 6. Summary of human serology results. Participants included in this table have PRNT titer ≥ 10. 
Area Serum # 
ELISA 
OD ratio 
PRNT 
titer result 
Travel history 
to endemic area Age Gender Profession 
Bekaa 
B9 2.64 40 No 75 Female Unemployed 
B11 5.47 ≥320 No 70 Female Unemployed 
B42 8.08 ≥320 Canada, 2008 83 Male Unemployed 
B75 2.66 10 No 45 Female Agriculture 
B116 7.30 ≥320 No 80 Male Unemployed 
B118 3.24 10 No 43 Male Unemployed 
B121 2.61 10 
Venezuella, 
2003 & Syria, 
2010 
51 Female Unemployed 
B133 5.00 160 Egypt, 2013 31 Male Private company 
B162 5.22 ≥320 No 65 Female Unemployed 
12 2.83 ≥320 No 85 Male Unemployed 
235 3.85 160 Brazil, 2003 & Syria, 2010 66 Female Unemployed 
237 3.25 160 Syria, 2013 73 Male Unemployed 
T57 5.08 ≥320 USA 76 Female Unemployed 
T167 5.35 ≥320 USA 82 Male Unemployed 
North 
25 1.71 10 No 74 Male Unemployed 
35 1.70 10 No 68 Female Unemployed 
U91 1.95 20 Germany, 2009 67 Female Unemployed 
U284 2.86 20 No 81 Male Unemployed 
 
Ten (5 females and 5 males) of the confirmed seropositive samples had more than 65 years 
old. All of them were either unemployed or housewives. One male seropositive participant is 31 
years old and works indoor in a private company. When analyzing travel history of seropositive 
participants, only four of them had travelled to countries endemic to WNV (Egypt, USA and 
Canada). The remaining seropositive participants, either had never travelled out of Lebanon (2 
patients) or had travelled to Syria or to other countries non-endemic for WNF (Table 6). These 
observations constitute a strong evidence of local circulation of WNV and local exposure of 
human population to this virus. 
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4. Serological study of horse population 
a. Description of horse sample population 
According to the Lebanese ministry of agriculture, the estimated number of horses in 
Lebanon is around 4000 horses. In this study, 202 horse samples were collected from 16 
different farms/stables in eight districts in Lebanon (Figure 27). Seven of them were ponies and 
the others belonged to different breeds such as Arabian, Thoroughbred, Dutch, Belgian Draft, 
Turkish, and the local breed called Alef which was the most represented breed in the study 
population (144 samples, 70.59%) (Figure 28). More than two thirds of the horse samples were 
females (140 samples, 69.31%). The age of included horses ranged from 4 months to 22 years 
with an average of 8.74 years (Figure 29). 
 
 
Figure 27. Pie chart showing the horse population distribution by district. 
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Figure 28. Pie chart showing the horse sample population breed distribution. 
 
 
Figure 29. Bar chart representing the age distribution of the horse population. 
 
b. Seroprevalence results 
ELISA testing showed that 10 sera samples had an OD ratio above 1.2 (Figure 30). Thus the 
seroprevalence rate is 4.95 % for the fixed threshold. PRNT was performed on these samples. It 
revealed that only four had neutralizing antibodies for WNV at a titer of 40 or higher (Table 7). 
Thus, the seroprevalence rate dropped to 1.98%. Only one horse had specific antibodies at titer 
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of 10. This serum was considered negative as it is below the fixed threshold. All positive horses 
were of Alef breed with no cross border movement history. They were recruited from farms in 
Tripoli, Aakar and Nabatiyeh districts. 
 
 
Figure 30. Scatter graph showing OD ratio obtained by ELISA on horse sera samples. The red line represents 
the fixed threshold (OD ratio = 1.2). 
 
Table 7. Summary of horse serology results. Samples included in this table have PRNT titer ≥ 10. 
Serum 
# 
ELISA 
OD ratio 
PRNT titer 
result Breed Age Gender Location 
83 1.371 160 Alef 7 Male Tripoli 
128 1.511 160 Alef 7 Female Aakar 
183 1.246 10 Alef 20 Female Nabatiyeh 
199 1.238 40 Alef 10 Female Nabatiyeh 
202 1.701 320 Alef 7 Female Nabatiyeh 
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5. Serological study of chicken population 
a. Description of the chicken study population 
In order to estimate the seroprevalence rate among chicken population, 163 chicken sera 
were sampled between September and December 2015 from 15 different locations. These 
chickens are of Leghorn breed and belonged to house poultries of residents and farmers in the 
Bekaa valley in West Bekaa, Zahle, and Baalbek districts. The majority (106 chickens, 65%) of 
the collected chicken originated from Zahle district (Figure 31). 
 
 
Figure 31. Pie chart representing the chicken sample population distribution by district. 
  
Similarly, the 20 chickens (10 white and 10 red) used for the seroconversion study part were 
of Leghorn breed. 
 
b. Seroprevalence results 
ELISA screening of chickens for WNV specific IgY did not reveal any clear positive serum. 
In fact, the OD ratios observed were all less than 1.2, except one serum that had an OD ratio of 
1.26 (Figure 32). Two chicken sera (those having the highest OD ratio value) were further tested 
by PRNT against WNV and both turned to be negative. Thus, in the present study, the observed 
seroprevalence rate against WNV among chicken is null. 
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Figure 32. Scatter graph showing OD ratio obtained by ELISA on chicken sera samples. The red line 
represents the fixed threshold (OD ratio = 1.2). 
 
c. Seroconversion results 
As for the temporal analysis of chicken sera by ELISA technique, results did not show any 
onset or increase of WNV specific antibody levels in any of the selected individuals in either 
locations. The observed OD ratios remained comparable in the three samples taken for each 
chicken (Figure 33). These results show that during the study period and in the Bekaa area, there 
was no detectable circulation of WNV and therefore, the tested chickens were not exposed to 
infectious bites of the mosquito vector. 
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Figure 33. Bar chart showing OD ratios of chicken samples of the seroconversion study. 
 
6. Statistical analysis 
Among serology results of human sample populations, no statistical significant differences 
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Discussion and Conclusion 
 
Lebanon is considered non-endemic and non-enzootic for WNV. To date, no WNF cases 
were officially reported. Our study brings a strong evidence of its occurrence in the country. The 
detection of relatively high titer of neutralizing antibodies IgG (≥320) in participants who never 
travelled out of the country confirms a local exposure to this virus. Moreover, the fact that all 
seropositive human cases (n=11) originated from the Bekaa area suggests that this region is the 
primary introduction site of WNV in the country. This area is considered a stopover zone for 
migratory birds. It harbors several water plans (Aammik swamps and Qaraoun lake) and 
important agriculture activities, which make it suitable for the introduction and local spread of 
the WNV. The detection of confirmed positive sera (by PRNT) among horses is an additional 
evidence of WNV circulation as all seropositive horses were of local breed with no record of 
cross-border transfer. However, their movement within the country did not allow us to conclude 
on the exposure area to WNV. 
The absence of WNV specific antibodies (IgY) in the poultry study population from the 
Bekaa and the absence of seroconversion in sentinel chickens suggest that there is no active 
current circulation of WNV in this region. Apparently, the circulation of WNV in Lebanon, 
when it occurs, seems to happen at low rate, which explains why human and animal cases have 
not yet been reported in the country. 
In a previous study, conducted by Gallian and collaborators (2010), among 639 Lebanese 
blood donors, six were WNV seropositive by ELISA among which only 3 (0.47%) were 
confirmed positive by PRNT at titers higher than 1/10. Seropositive participants lived in South 
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Lebanon, Beirut, and the Bekaa however the authors did not specify whether these participants 
had any travel history or not (Gallian et al., 2010). 
The observed seroprevalence rate in our study, although relatively low, is comparable to 
what is usually reported from geographically close endemic countries such as in Greece where 
the seroprevalence rate was 1.02% following confirmation by PRNT (Papa et al., 2010). In the 
neighboring Turkey, the WNV seroprevalence rate, as also confirmed by PRNT, have been 
reported to be as low as 0.8% in blood donors (Ayturan et al., 2011), and as high as 17% in 
Mardin province (near the Syrian border) among human population following the appearance 
suspected encephalitis cases (Karakoç et al., 2013). In another study conducted in the Manisa 
province on the Aegean Sea, West of Turkey, 4.3% of tested sera of healthy rural residents were 
seropositive following ELISA screening and confirmation by IIFA (Gazi et al., 2016). Similarly, 
in Egypt, WNV neutralizing antibodies (by PRNT) were found in humans and the rate varied 
from 1% (in Northern Sinai) to 35% (in Upper Egypt) (Soliman et al., 2010). In Jordan, that, like 
Lebanon, is considered non-endemic for WNV, the seroprevalence rate was estimated at 8% in 
care center population following screening by ELISA (Batieha et al., 2000). 
In Israel, a country at the Southern border of Lebanon, WNV has been responsible for several 
outbreaks. In the year 2000, hundreds of cases were reported from this country, mainly from the 
central and northern regions, close to Lebanon (Weinberger et al., 2001). A cross-sectional study, 
involving more than 3100 healthy individuals recruited between 2011 and 2014, showed that 
11% of subjects had specific antibodies IgG for WNV following screening by ELISA and 
confirmation by PRNT. This study revealed that the Coastal Plain, the Inland Plain and the Great 
Rift Valley, which is a geographic extension of the Bekaa valley, had the highest seroprevalence 
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of WNV antibodies (Bassal et al., 2017). These observations suggest that WNV has a lower 
prevalence in Lebanon than in Israel.  
The serosurvey among horses revealed a 4.95% seropositive rate for WNV by ELISA which 
dropped to 1.98% after PRNT. All confirmed positive horses (n=4) came from different 
geographical locations (Tripoli, Aakar and Nabatiyeh). These results represent the first record of 
equine exposure to WNV in Lebanon. The observed seroprevalence rate is considered low 
compared to that observed in neighboring or distant endemic countries. In Turkey, following the 
WNV outbreak in 2011, the seroprevalence rate among horses was 21% after confirmation by 
PRNT (Ozkul et al., 2013). In South of France, following an outbreak among horses in 2000, a 
serosurvey conducted among equines revealed a seroprevalence rate of 8.5% by ELISA (Durand 
et al., 2002). Moreover, in Ukraine, a similar study was conducted in 2013 following limited 
WNV outbreak among humans in 2011 and 2012 and showed a seroprevalence rate of 13.5% by 
PRNT (Ziegler et al., 2013). Nevertheless, the seroprevalence observed in our study is 
comparable to what was reported from Iran where the endemicity of WNV is considered 
relatively low among both human and horses. Following screening by ELISA technique, WNV 
seroprevalence rate among horses (N=315) was 2.8% (Chinikar et al., 2013). Interestingly, in 
Jordan and Algeria, the seroprevalence rates among horses using ELISA technique were 24.9% 
and 26.8% respectively (Abutarbush and Al-Majali, 2014; Lafri et al., 2017). In the absence of 
confirmation by PRNT, these high rates should be carefully interpreted since they can reflect the 
circulation of not only WNV, but also other Flaviviruses. 
The ELISA technique is considered a screening method to test a relatively large number of 
sera. This technique is very sensitive but can lead to the detection of false positive sera due to the 
cross-reaction with other Flaviviruses (such as Dengue Virus, Zika virus, Usutu virus, or other 
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viruses) that might be circulating in the region without being noticed. Previous studies in 
Lebanon confirmed arbovirus circulation in 1945-1946, in which an epidemic of Dengue fever 
was reported from Beirut region and affected more than 100,000 individuals (Hitti and 
Khairallah, 1946). Another serological survey conducted during 1962-1963 showed a 
seroprevalence for DENV of 61.9% using hemagglutination-inhibition test (Garabedian et al., 
1971). Besides, the tiger mosquito (Aedes albopictus) is well spread in Lebanon (Haddad et al., 
2007). Lebanese strains of this mosquito appear to be able to transmit Dengue virus under 
experimental conditions (Haddad et al., 2012). Moreover, the tiger mosquito is a possible vector 
of Zika virus (Wong et al., 2013). The exposure of Lebanese population to this virus was never 
assessed. Thus, and in order to increase the specificity of sera screening, all ELISA positive 
samples were confirmed by PRNT, a clearly more specific technique than other serological 
methods. It is worth noting that 65 sera samples had high OD ratio by ELISA but did not have 
neutralizing antibodies against WNV. This observation suggests the circulation of other 
Flaviviruses which should be identified. 
According to the Society for the Protection of Nature in Lebanon (SPNL) and Bird Life 
Lebanon, there are more than 300 bird species in the country. Migratory birds in Lebanon 
include Cranes, Pelicans, Common Buzzard, Lesser Spotted Eagle, and White Storks (SPNL, 
2017). Some of these species of wild and domestic birds were seropositive against WNV in 
endemic countries such as Israel (Di Sabatino et al., 2014), Greece (Valiakos et al., 2011), 
Hungary (Erdélyi et al., 2007), and USA (Nash et al., 2001; Steele et al., 2000). Moreover, in 
Germany, during 2005-2009, a study detected WNV neutralizing antibodies in 10 species of 
migratory birds, but not in resident birds (Seidowski et al., 2010). Migratory birds are very 
difficult to monitor. It was proven that chickens are very sensitive to WNV infection but they 
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usually do not develop clinical symptoms. Besides, they develop relatively low viremia that is 
insufficient to infect mosquito vectors (Langevin et al., 2001). Nevertheless, following 
infections, these birds develop detectable neutralizing antibodies. Consequently, chickens are 
largely used during WNV surveillance programs as sentinel animals to detect the circulation of 
the virus.  In order to assess WNV circulation, we screened Leghorn chickens for viral exposure. 
These chickens have a life span of 1 to 6 years. Therefore, their serological monitoring is useful 
to detect relatively recent WNV infection. In our study, we were not able to detect WNV 
exposure. To our knowledge, no other studies attempted to assess the circulation of WNV neither 
in domestic nor in migratory birds in Lebanon.  
Our entomological surveys in Bekaa and Akkar revealed high presence of Culex pipiens, the 
known primary vector of WNV. Moreover, another potential vector, Culex perexiguus, was also 
present but in limited numbers. These findings are in concordance with previous studies (Knio et 
al., 2005) and entomological surveys conducted by our laboratory (unpublished data). Molecular 
analysis results revealed that none of the mosquito pools was found naturally infected with 
WNV. This is not very surprising if we consider the low circulation of the virus in the country as 
suggested by the observed low seroprevalence rates among human and horses. Therefore, a much 
higher number of mosquitoes should have been screened in order to increase the chances of virus 
detection in the potential vectors. 
In the EMR, WNV was naturally isolated from different Culex species in endemic countries 
in which the seroprevalence rates among human and horses were much higher than those 
observed in the present study. In Turkey, after an outbreak in 2012, WNV was isolated from 
1.9% of collected mosquito pools (Ergunay et al., 2013). Whereas in Israel, analysis of 277186 
mosquitoes collected during 15 years (1985-2000), allowed the detection of WNV lineages 1 and 
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2 in 336 mosquito pools (Lustig et al., 2016). The virus was isolated from 2.39% and 9.22% of 
Cx. pipiens and Cx. perexiguus pools respectively (Lustig et al., 2016). Lustig and collaborators’ 
observations in 2016 highlighted the role of this latter species in the spread of the virus. This 
mosquito was previously associated with WNV infection. Following molecular screening of 
almost 430,000 mosquitoes collected during eight consecutive years (2000-2007), the majority of 
WNV infections were found in the three most common species: Cx. pipiens, Cx. perexiguus, and 
Ae. caspius. The WNV infection rate of Cx. perexiguus (2.6%) was significantly higher than 
those of the first and the third species (0.5% and 0.8% respectively) (Orshan et al., 2008). In the 
same study, the authors noticed that in the year 2004, when a sharp decline of the number of 
human cases occurred, only Cx. perexiguus was found infected. In Spain, Munoz and 
collaborators (2012) analyzed the feeding pattern of different potential WNV vectors belonging 
to the Culex genus. They noticed that the feeding behavior of Cx. perexiguus is in favor of WNV 
transmission from bird to bird and from bird to horse, this mosquito species being then the 
primary candidate for enzootic (bird-to-bird) transmission and for epizootic transmission to 
horses (Muñoz et al., 2012). The authors noticed that Culex pipiens is also an enzootic vector, 
but has only a low risk for epizootic transmission to humans. In Lebanon, the ecology of both 
vectors should be further investigated in order to better understand the pattern of transmission of 
WNV in the country. 
In conclusion, during this study, we were able to confirm that WNV circulates in Lebanon. 
This circulation was more obviously detected in the Bekaa region where the seroprevalence rate 
for humans was 1.37%. Besides, and for the first time, we detected seropositive horses in the 
country (1.98%). We assume that the exposure to WNV is not recent as no seroconversion in 
sentinel chickens and no WNV particles in mosquito populations were detected. Culex pipiens, 
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the most abundant mosquito species, is the suspected vector. Besides, Cx. perexiguus, a known 
WNV vector in the East Mediterranean Region, was also present but in limited numbers.  The 
feeding behavior of both mosquitoes should be analyzed in order to determine their implication 
in the transmission cycle. We recommend conducting similar surveys for several consecutive 
years in order to detect potential introduction of WNV to Lebanon. 
  
100 
 
Chapter 7 
Experimental transmission of West Nile Virus and Rift Valley Fever Virus by Culex pipiens 
from Lebanon 
 
In this chapter, we present the submitted article to Plos Neglected Tropical Diseases journal. 
Peer reviewing is under process. 
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Introduction 
 
West Nile virus (WNV) and Rift Valley fever virus (RVFV) are two important emerging 
mosquito-borne zoonotic agents transmitted by Culex pipiens, a complex of sibling species that 
includes Cx. pipiens s.s., Cx. quinquefasciatus and possibly Cx. australicus (Harbach, 2012; 
Turell, 2012). Cx. pipiens s.s. includes two biotypes or subspecies: Cx. pipiens pipiens and Cx. 
pipiens molestus (Fonseca et al., 2004; Harbach, 2012). The first biotype is primarily a bird-
feeding mosquito present in temperate areas while Cx. pipiens biotype molestus feeds on 
mammals (mainly human) and thrives in sewers in temperate and sub-tropical regions (Bahnck 
and Fonseca, 2006; Fonseca et al., 2004). Because morphological identification of these biotypes 
is not possible, they can only be distinguished using molecular techniques (Bahnck and Fonseca, 
2006; Fonseca et al., 2004; Price and Fonseca, 2015). 
WNV is a member of the Flavivirusgenus (Flaviviridae family) and was first isolated in 
Uganda in 1937 (Smithburn et al., 1940). Usually, only 20% of infected individuals develop 
symptoms and less than 1% of infected people develop serious and potentially fatal neurological 
illnesses such as meningitis and encephalitis. Birds are considered the main reservoir of the virus 
and Cx. pipiens is recognized as the primary enzootic vector (Andreadis, 2012). WNV infections 
have been reported in many tropical and temperate countries in Africa, Europe, Asia and 
America. The Middle East and North Africa (MENA) region has been long considered as a 
WNV-endemic area (Marka et al., 2013; Murgue et al., 2001a). Locally acquired cases have been 
recently reported in Israel (Paz and Semenza, 2013), Greece (Papa, 2017), Turkey (Failloux et 
al., 2017), and Italy (Calistri et al., 2010). In addition, evidence of WNV circulation has been 
reported in Jordan (Batieha et al., 2000) and Egypt (Soliman et al., 2010). The introduction of 
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WNV into the United States in 1999, which constitutes a turning point in WNV epidemiology, is 
thought to have originated from Israel following introduction from Africa (Giladi et al., 2001; 
Lanciotti et al., 1999). 
RVFV belongs to Phlebovirus genus (Bunyaviridae family). It was first identified in Kenya 
in 1931 (Daubney et al., 1931). This virus usually affects livestock and causes abortion. The 
main enzootic vectors belong to the Aedes genus (Tantely et al., 2015). However, several Culex 
species, including Cx. pipiens are considered secondary vectors and contribute to the 
transmission of WNV to humans (Tantely et al., 2015). Infected people can be asymptomatic or 
develop a mild febrile disease. In less than 10% of cases, people may develop more severe 
symptoms such as encephalitis and hemorrhagic fever. RVFV was responsible for numerous 
outbreaks among animals and humans in Sub-Saharan Africa (Himeidan et al., 2014) up to 
Mauritania (El Mamy et al., 2011) but also in Egypt (Meegan, 1979). In the Middle East, 
epizootics were reported in Saudi Arabia and Yemen (Ahmad, 2000). 
In Lebanon, Cx. pipiens is a predominant mosquito species besides another vector of 
arboviruses, Aedes albopictus (Haddad et al., 2007; Knio et al., 2005). Cx. pipiens colonizes 
urban and rural habitats whereas Ae. albopictus is mostly present in the densely populated 
coastal fringe. Local Ae. albopictus are competent to transmit Chikungunya virus and to a lesser 
extent, Dengue virus (Haddad et al., 2012). The vector competence of local populations of Cx. 
pipiens to transmit WNV and RVFV has never been evaluated. Diseases caused by these two 
viruses have never been reported in Lebanon. Nevertheless, a serological study conducted in a 
main hospital in the capital city of Beirut, confirmed the presence of neutralizing WNV 
antibodies in blood donors (Gallian et al., 2010). In fact, Lebanon is situated in a WNV-endemic 
area and located on the flyways of migratory birds with potential introduction of the virus into 
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the country. Moreover, Lebanon is geographically close to Yemen and Saudi Arabia, regions 
where RVFV had circulated actively. Intensive livestock trade between Lebanon and these 
countries increases the risk of RVFV introduction. 
Here, we assess the vector competence of local populations of Cx. pipiens towards WNV 
and RVFV. For each Cx. pipiens biotype, we estimate viral infection, dissemination and 
transmission at different days after experimental infections. 
 
Material and Methods 
Mosquito collections 
Culex egg rafts were sampled in June 2015 in Bab Mareh, in the West Bekaa district, a sub-
humid, agricultural area in east of Lebanon with large stagnant water systems (Fig. 34). Egg rafts 
were collected on the water surface in an artificial basin and placed individually in a tube 
containing 30mL of water collected from the breeding site. 
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Figure 34. Map showing the geographic location of Lebanon East of the Mediterranean basin. This map 
indicates the site of mosquito egg collections in West Bekaa region. The map was modified using PowerPoint from 
http://landsatlook.usgs.gov/ (Credit: U.S. Geological Survey Department of the Interior/USGS --U.S. Geological 
Survey). Photo: breeding site (N. Haddad). 
 
Mosquito preparation for vector competence study 
Collected egg rafts were shipped to the Laboratory of Arboviruses and Insect Vectors (AIV) at 
the Institut Pasteur, Paris. They were reared until the adult stage. Adults emerging from each raft 
were morphologically identified and only Cx. pipiens species were retained for this study. 
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Viruses and blood meal preparation 
Two viruses were used in this study: WNV lineage 1 strain isolated from a horse in Camargue 
(France) in 2000 (Murgue et al., 2001b) and an avirulent RVFV strain Clone 13 isolated from a 
human case in Bangui (Central African Republic) in 1974 (Muller et al., 1995). After passages 
on Vero (E6) cells (ATCC cell lines), both viruses were produced on C6/36 mosquito cells. Viral 
stocks were stored at -80°C until use. The infectious blood meal was composed of a viral 
suspension (1:3) diluted in washed rabbit erythrocytes (New Zealand White rabbit, Charles 
River) collected at the day of mosquitoes infection. A phagostimulant (ATP) was added at a final 
concentration of 5mM. Virus titer in the blood meal was 1.6×108plaque forming units (PFU)/mL 
for WNV and 1.33×107 PFU/mL for RVFV. 
 
Artificial feeding of female mosquitoes 
The susceptibility of Lebanese Cx. pipiens mosquitoes to WNV and RVFV was tested on F0 and 
F1 generation respectively. Ten-to-twelve day-old female Cx. pipiens mosquitoes were left to 
starve for 48 h in Biosafety Level 3 (BSL3) insectary at 28±1°C with 80% relative humidity and 
a 16h:8h photoperiod. Females were then allowed to feed for one hour through a chicken skin 
membrane (obtained from a commercially purchased chicken) covering the base of a capsule of 
the feeding system (Hemotek) containing the blood-virus mixture maintained at 37°C. Fully 
engorged females were sorted, then transferred in cardboard containers and maintained with 10% 
sucrose at 28±1°C until examination. 
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Saliva collection 
Around 20 female mosquitoes were tested at 3, 7, 14 and 19 days post-infection (dpi). For each 
mosquito, saliva was collected using the forced salivation technique (Dubrulle et al., 2009). 
Briefly, mosquitoes were chilled, their legs and wings removed and the proboscis was inserted 
into 20µL tip filled with 5µL of Fetal Bovine Serum (FBS). After 45 min, medium containing 
the saliva was expelled into 0.2mL tube containing 45µL of Dulbecco’s MEM (DMEM) 
medium. Collected saliva and the remaining mosquito bodies were conserved at -80°C for further 
analysis. 
 
Viral detection in mosquitoes 
In order to assess the ability of both viruses to invade and cross the midgut barrier, the infection 
rate (IR) and the dissemination efficiency (DE) were determined. IR reflects the proportion of 
female mosquitoes with infected bodies (thorax and abdomen including the midgut) among 
tested specimens while DE is the proportion of female mosquitoes with infected head (detection 
of the virus having succeeded to reach the mosquito general cavity) among tested ones. Thus, 
heads and bodies were separated and ground each in 300µL DMEM supplemented with 3% FBS. 
After centrifugation, the supernatant of each homogenate was conserved at -80°C. Then, 20µL of 
each sample were diluted in 180µL DMEM supplemented with 2% FBS and distributed in serial 
dilutions from 10-1 to 10-3 in duplicates on Vero cell monolayers (3.105cells/well) in 96-well 
plates. After incubation at 37°C for 6 days, inoculum was removed and the cells were fixed and 
stained using a crystal violet solution (0.2% in 10% formaldehyde and 20% ethanol). After 
washing, the presence or absence of cytopathic effect was noted. 
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The capacity of the WNV and RVFV to cross the salivary glands barrier was evaluated by 
determining the transmission efficiency (TE) which corresponds to the proportion of female 
mosquitoes that secrete infectious saliva among tested specimens. The number of infectious 
particles within collected saliva samples was estimated on Vero cell culture and expressed as 
PFU/saliva. Briefly, 20µL of each saliva were diluted in 280µL DMEM 2% FBS. The total 
volume was inoculated on a monolayer of Vero cells (8.105cells/well) in six-well plates. Cells 
were incubated at 37°C for 6days under an overlay consisting of DMEM, 2% FBS, 1% 
antibiotic-antimycotic mix and 1% agarose. The lytic plaques were counted after staining with a 
crystal violet solution. 
 
Statistical Analysis 
Proportions (IR, DE and TE) were compared using Fisher’s exact test and sample distributions 
(number of viral particles) with the Kruskal-Wallis test. Statistical analyses were conducted 
using the Stata software (StataCorp LP, Texas, and USA). P-values <0.05 were considered 
significant. 
 
Results 
Artificial feeding 
Collected egg rafts were hatched in laboratory conditions and provided 480 adult females of 
Culex pipiens (F0 generation); of those only 174 (36.25%) had successfully fed on a WNV-
infected blood. A batch of 600 F1 female mosquitoes was used for the RVFV infection assay. Of 
those, only 91 (15.16%) had successfully fed on infected blood. 
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Viral infection 
Infection rate (IR) for each virus was estimated by determining the number of infected bodies 
(abdomen and thorax) among all engorged female mosquitoes examined at each dpi (3, 7, 14 and 
19) (Fig. 35A). For WNV, IRs were very high (94.7-100%) from 3 to19 dpi. For RVFV, IRs 
were much lower: at 3 dpi, the IR was 44% ±12.05 (mean±SE) and increased gradually to reach 
65% (±10.9) at 14 dpi and 64.3 (±13.3) at 19 dpi. 
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Figure 35. Infection (A), Dissemination (B) and Transmission (C) of Culex pipiens at different days after 
ingestion of an infectious blood meal containing WNV or RVFV. Culex pipiens F0/F1 mosquitoes were orally 
challenged with WNV at a titer of 1.6×108 PFU/mL and RVFV at titer of 1.33×107 PFU/mL using an artificial 
feeding system (Hemotek). At 3, 7, 14, and 19 dpi, homogenates of mosquito bodies and heads, and saliva collected 
from females were tested for the presence of virus on Vero cells to estimate infection rate, dissemination efficiency, 
and transmission efficiency, respectively. In brackets, the number of tested mosquitoes. Error bars show the 
confidence interval (95%). 
110 
 
Viral dissemination 
The detection of viral particles in mosquito heads allowed estimating the ability of the virus to 
disseminate from the midgut to internal organs. For WNV, dissemination efficiency (DE) 
increased from 31.6% (3 dpi) to 94.7% (19 dpi) (Fig. 35B). For RVFV, virus was only detected 
at 19 dpi with a DE of 21.4% (±10.9) (Fig. 35B). 
 
Viral transmission 
The ability of mosquitoes to transmit the virus was measured by detecting viral particles in saliva 
expectorated by mosquitoes. With WNV, transmission efficiencies were much higher than with 
RVFV (Fig. 35C). At 3 dpi, 10.5% (±7.0) of mosquitoes had WNV particles detected in their 
saliva. TE increased gradually to reach 86.4% (±7.3) at 14 dpi and slightly dropped to 68.4% 
(±10.9) at 19 dpi. For RVFV, viral particles were only detected in saliva at 19 dpi with a TE of 
7.1% (±6.9) (Fig. 35C). 
 
Intensity of transmission 
Mosquitoes were able to deliver an average of 550 (±450) PFU/saliva at 3 dpi with WNV, which 
increased to reach1004 (±442) PFU/saliva at 7 dpi (Fig. 36). Despite a decrease at 14 dpi, the 
viral load remained high at 19 dpi with 1028 (±405) PFU/saliva. For RVFV, only one female had 
infectious particles in saliva at 19 dpi with a viral load of 42 PFU (Fig. 36). 
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Figure 36. Mean titer of infectious viral particles secreted in saliva of Culex pipiens at different days after 
ingestion of an infectious blood meal containing WNV or RVFV. The number of infectious particles in saliva 
was estimated by inoculation of collected saliva on Vero cells and expressed as pfu/saliva. In brackets, the number 
of tested mosquitoes. Error bars refer to the standard error. 
 
Vector competence of Cx. pipiens biotypes 
Mosquitoes previously examined were then analyzed according to their biotype. When infected 
with WNV, the three biotypes presented similar IR, DE and TE at each dpi (Fisher’s exact testμ p 
>0.05) (Fig. 37A-C). Cx. pipiens molestus started to transmit WNV from 3 dpi while pipiens 
biotype from 7 dpi and hybrids from 14 dpi. When infected with RVFV, IR, DE and TE were 
slightly similar at each dpi whatever the biotype (Fisher’s exact testμ p > 0.05) (Fig. 38A-C). 
RVFV was only detected in saliva of Cx. pipiens biotype pipiensfrom 19 dpi. No virus was 
detected in saliva of molestus and hybrid biotypes. For these results, it is important to consider 
the low number of individuals analyzed. 
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Figure 37. Comparison between Culex pipiens biotypes challenged with WNV: infection rate (A), 
dissemination efficiency (B) and transmission efficiency (C). Mosquito legs or wings were used to amplify the 
CQ11 gene ofCx. pipiens, a diagnostic gene to distinguish the two Cx. pipiens biotypes and their hybrids. IR, DE 
and TR were calculated for each biotype. In brackets, the number of tested mosquitoes. 
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Figure 38. Comparison between Culex pipiens biotypes challenged with RVFV: infection rate (A), 
dissemination efficiency (B) and transmission efficiency (C). Mosquito legs or wings were used to amplify the 
CQ11 gene of Cx. pipiens, a diagnostic gene to distinguish the two Cx. pipiens biotypes and their hybrids. IR, DE 
and TR were calculated for each biotype. In brackets, the number of tested mosquitoes. 
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When comparing the amount of virus expectorated by the two Cx. pipiens biotypes and their 
hybrids, they delivered more than 500 viral particles from day 3 for molestus biotype, day 7 for 
pipiens biotype and day 14 for hybrids (Fig. 39A). Only one Cx. pipiens biotype pipiens 
delivered 42 particles of RVFV in saliva at 19 dpi (Fig. 39B). 
 
 
Figure 39. Mean number of viral particles of WNV (A) and RVFV (B) in saliva of the biotypes of Cx. pipiens 
examined at different days after ingestion of an infectious blood meal provided. Blood meals were provided at a 
titer of 1.6×108 PFU/mL for WNV and 1.33×107 PFU/mL for RVFV. The number of infectious particles in saliva 
was estimated by inoculation of collected saliva on Vero cells and expressed as PFU/saliva. In brackets, the number 
of tested mosquitoes. Error bars refer to the standard error. 
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Discussion 
Culex pipiens is the most widely distributed mosquito species in Lebanon and is suspected to 
transmit WNV and RVFV in several countries (Andreadis, 2012; Tantely et al., 2015). Using 
experimental infections, we showed that Cx. pipiens populations collected from West Bekaa, 
Lebanon were susceptible to infection by these two viruses and ensured efficient transmission of 
WNV and to a lesser extent, RVFV. 
When exposed to an infectious blood-meal containing WNV, Cx. pipiens was capable to 
ensure viral infection, dissemination and transmission starting from 3 dpi. Most mosquitoes 
exposed to the infectious blood-meal were infected as IRs reached 100% at the 4 dpi examined 
(3, 7, 14 and 19 dpi). Dissemination and transmission were slightly lower suggesting that not all 
infected mosquitoes were able to transmit WNV. Mosquitoes delivered more than 500 viral 
particles in saliva from 3 dpi. Based on these results, Cx. pipiens can be qualified as a competent 
vector of WNV. On the other side, infections with RVFV present different patterns: lower IR, 
DE and TE. 44 to 64% of mosquitoes remained infected from 3 to 19 dpi. Only21% of 
mosquitoes were able to ensure viral dissemination at 19 dpi and 7% were able to transmit at 19 
dpi. This suggests a significant role of the midgut and the salivary glands as respective barriers to 
the release of viruses into the body cavity and their excretion in saliva (Kramer and Ebel, 2003). 
In this manner, Cx. pipiens was less susceptible to RVFV than to WNV. 
Overall, Cx. pipiens can transmit experimentally both viruses but the time interval between 
the ingestion of the viremic blood-meal and the ability to transmit the virus termed the extrinsic 
incubation period (EIP) was 3 days for WNV and 19 days for RVFV. Cx. pipiens from Tunisia 
showed similar EIP of 3 days with WNV and a much shorter EIP of 3 days with RVFV 
(Amraoui et al., 2012) underlining the significant role of mosquito genotype in specific 
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interactions between mosquito and virus genotypes; these interactions promoting adaptation of 
viral lineages to specific mosquito vector genotypes influence the outcome of transmission 
(Fansiri et al., 2013). In addition, when viral dose increases in blood meals, transmission 
efficiency also increases suggesting that hosts presenting a high viremia may infect more 
mosquitoes (Martin et al., 2010). Animals susceptible to RVFV can develop very high viremia, 
higher than 1010.1 MIPLD50 (mouse intraperitoneal 50% lethal dose/mL) in lambs (Easterday et 
al., 1962). Then, at higher titers of blood meal, RVFV may infect more mosquitoes. 
Our study showed that different biotypes of Cx. pipiens exhibit different vector 
competence to WNV and RVFV. Cx. pipiens biotype molestus transmits earlier WNV than 
pipiens and hybrid biotypes. Therefore, Cx. pipiens biotype molestus has the shortest EIP under 
our experimental conditions. Mosquitoes of the molestus biotype persist all year long (not able to 
diapause during winter), are autogeneous (lay the first batch of eggs without taking a blood-
meal) and stenogamous (mate in confined spaces) mainly in underground areas in cities 
(Harbach et al., 1985). Mosquitoes of this biotype feed mainly on mammals and then can 
potentially transmit pathogens such as WNV to humans. It can be suggested that the molestus 
biotype predominant in urban settings could intervene in an inter-human transmission of WNV. 
It has been shown that transmission of WNV by molestus was not affected by temperature 
(Vogels et al., 2016); the colonization of hypogenous sites (where temperatures are more stable) 
may lead to select genetically differentiated mosquito populations more adapted to this 
environment with presumably effects on their phenotypic characteristics including vector 
competence for arboviruses. 
With RVFV, the biotype pipiens was alone capable of transmitting the virus at 19 dpi. 
While the infection was efficient from 3 dpi for the three biotypes, only Cx. pipiens biotype 
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pipiens was able to disseminate the virus at 19 dpi. This result indicates that the midgut plays a 
significant role of barrier to the release of the virus into the mosquito general cavity. Moreover, 
the RVFV strain Clone 13 which is a naturally attenuated virus characterized by a deletion of 
70% of the NSs gene encoding for a virulence factor (Billecocq et al., 2004; Le May et al., 2004) 
replicates differently in mosquitoes. Viral dissemination was higher when mosquitoes were 
exposed to a virulent RVFV such as ZH548 (Moutailler et al., 2008). In our study, only one Cx. 
pipiens biotype pipiens was able to transmit the virus at 19 dpi with 42 viral particles detected in 
saliva. This viral load was more than 14 times lower than the dose detected in Cx. pipiens 
mosquitoes from the Maghreb region (i.e. 620 viral particles) (Amraoui et al., 2012), but 
probably enough to infect hosts, animals and humans. 
 
In conclusion, the predominant Cx. pipiens mosquito in Lebanon is susceptible to both 
viruses, WNV and RVFV. The biotype molestus can transmit WNV earlier than pipiens and 
hybrid biotypes whereas the biotype pipiens acts as the sole efficient experimental vector of 
RVFV, i.e. capable of transmitting at late days post-infection. As Lebanon is located in a region 
where WNV and RVFV can be potentially introduced (respectively through migratory birds and 
animal trades), local health authorities should establish an active surveillance to detect any new 
human cases in addition to reinforce the entomological surveillance allowing an early viral 
detection in field-collected mosquitoes. 
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Chapter 8 
General Discussion and Perspectives 
 
WNV and RVFV are mosquito-borne viruses. Their introduction to a given country usually 
occurs following the introduction of viremic hosts. The vector capacity of the local vectors is the 
determinant factor that would allow the transmission of these viruses in the country. This 
capacity does not depend only on the receptivity of the vector to the virus but also on several 
extrinsic factors such as attractiveness to the host and vector density. Culex pipiens is a potential 
vector for both viral species. In the Middle East, high human population density  and  human-
induced habitat changes creating potential mosquito breeding sites favor the presence of this 
mosquito (Conley et al., 2014). 
The transmission of WNV occurs in Lebanon as we were able to demonstrate the exposure of 
local hosts (humans and horses) to this virus. The Bekaa plane is the probable introduction 
region of the virus. Besides, Culex pipiens of this region showed to be receptive to WNV. The 
biotype molestus which is known to feed on mammals including humans and also on birds 
(Harbach, 2012), showed a shorter EIP than the pipiens biotype under our experimental 
conditions. Therefore, molestus biotype is highly competent to ensure transmission of WNV to 
humans. The observed low endemicity of this virus, compared to what is usually observed in the 
neighboring Israel, that is located on the same flyway of migratory birds as Lebanon, is 
intriguing. The climatic conditions of the Bekaa plane, which is a plateau of 800-900 m of 
altitude, during the bird migration season, could explain this difference. Indeed, during spring 
(northward migration) and fall (southward migration), the local temperatures in the Bekaa valley 
are not high enough and consequently, mosquito population densities are not very important. 
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WNV does not seem to be the only flavivirus circulating in Lebanon as shown in the 
important cross-reactivity with WNV antigens by the In-House ELISA testing. Several avian 
flaviviruses, occurring in Africa, are likely to occur in the EMR, including Lebanon, through bird 
migration as one of their major routes from Africa passing through the Middle East (Figure 17). 
Bagaza virus (BAGV), which was recently considered a synonymous of Israel Turkey 
Menigoencephalitis virus (Fernández-Pinero et al., 2014), is one of these avian flaviviruses that 
can potentially occur in the EMR. This virus affects mainly birds; however, specific antibodies 
were detected in patients suffering from encephalitis in India (Bondre et al., 2009). Usutu Virus 
(USUV) is another avian flavivirus, with more zoonotic potential, that can be spread to the EMR. 
This virus was described in South Africa and was introduced to Europe where it caused sudden 
death in birds and affected several immune-compromised persons in Italy during the year 2009 
(Becker et al., 2012; Savini et al., 2011). Both BAGV and USUV can be transmitted by Cx. 
pipiens (Braverman et al., 2003; Calzolari et al., 2010). 
Non-Avian Flaviviruses could also circulate in Lebanon. Dengue virus was historically 
spread in the EMR. Since the elimination of its vector, Ae. aegypti at that time, the country is 
considered Dengue free. Nevertheless, the currently established Ae. albopictus can ensure the 
transmission of this disease (Haddad et al., 2012) as it occurred in some Mediterranean countries 
(Gjenero-Margan et al., 2011; La Ruche et al., 2010; Marchand et al., 2013). In addition, Zika 
virus can be also transmitted by Ae. albopictus as suggested by field and laboratory based 
observations (Chouin-Carneiro et al., 2016; Grard et al., 2014; Wong et al., 2013). The 
involvement of Cx. pipiens in the transmission of this virus is unlikely (Amraoui et al., 2016). 
The potential introduction of RVFV to Lebanon depends on the livestock trade with 
countries in Africa and even in the Arabian Peninsula, where the virus occurs. Culex pipiens 
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from Lebanon, did not seem to be very competent to transmit RVFV. However, the exposure of 
this dominant mosquito to a highly viremic animal could lead to an efficient transmission of the 
virus. Moreover, the possibility of this virus to be locally transmitted by other mosquitoes, 
especially those of the Aedes genus, should be considered. Based on field observation, Aedes 
albopictus, is the most dominant species of this genus in Lebanon (Haddad et al., 2012). The role 
of this species in transmitting RVFV was suggested by Turell and collaborators (1988). In a 
vector competence study conducted on Ae. albopictus strains from Texas (USA), 15% of the 
orally infected mosquitoes, with a disseminated infection, transmitted the virus. This rate is 
similar to what was observed in Aedes mcintoshi that has been implicated in RVFV transmission 
in Africa (Turell et al., 1988). The vector competence of the Lebanese tiger mosquito toward this 
virus needs to be assessed. 
RVF epidemics are more and more frequent in Africa (CDC, 2017) and in some countries of 
the Middle East, probably in relation with climatic changes and intensified livestock trade 
(Chevalier et al., 2010). Therefore, the probability of spread of RVF outside the historically 
known endemic area remains a possibility especially to regions with large population of 
livestock. Therefore, control measures especially on imported animals should be reinforced. 
Current and previous entomological observations confirmed the dominance of two important 
vectors: Cx. pipiens and Ae. albopictus species. Both species are competent vectors to several 
arboviruses that are likely to be introduced to Lebanon as the result of globalization and climate 
change. Consequently, vector control programs that have ceased since 1975, at the beginning of 
the Lebanese war, should resume in order to prevent a potential local spread of these pathogens. 
Our study gave evidence, for the first time, of WNV circulation in human and horses in 
Lebanon. Although the circulation seems to appear at a low pace, we observed a 1.01% and 
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1.98% seroprevalence rates against WNV among human and horses respectively (after PRNT). 
In addition, experimental infections of Cx. pipiens from Lebanon showed that these local 
mosquitoes are competent vectors of WNV and to a lower extent, RVFV. In this study, we were 
able to identify molestus and pipiens biotypes and their hybrid in the country. Both biotypes were 
competent to transmit WNV, while the molestus biotype had a shorter EIP and therefore can 
ensure faster transmission of this virus. 
In this project we were able to describe important elements related to the epidemiology of 
WNV in Lebanon, however we failed to characterize the identity of the virus certainly because of 
the observed low endemicity. Nevertheless, this study highlighted the potential circulation of 
other flaviviruses in the country. Therefore, and in order to gather more epidemiological 
information, we suggest to perform the following studies: 
 Repeat serosurveillance study on larger numbers of chickens and use more sentinel birds 
in order to pick up potential future circulation of WNV. 
 Carry out additional entomological studies and screen by molecular tools greater numbers 
of mosquitoes for WNV or even for flaviviruses using generic primers. 
 Conduct molecular screening for flaviviruses on cerebrospinal fluids of patients with 
aseptic meningitis in order to detect neuroinvasive flaviviruses. 
 Conduct serological and entomological studies in new geographical areas such as in the 
South that border with the endemic Israel. 
 Establish a surveillance system to conduct regular monitoring of horses to detect any 
potential exposure to WNV. 
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 Study blood preferences and feeding behaviors of Culex pipiens and other Culex species 
(such as Cx. perexiguus) in order to understand their potential involvement in WNV 
transmission cycle. 
Finally and based on all the above observations, we invite local authorities to start an 
integrative surveillance system that include entomological monitoring and control programs in 
addition to human and animal serological screening programs in order to detect the introduction 
and prevent the spread of potential arboviruses. 
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Appendix A: Informed Consent Form in Arabic 
ملع Ϧع ΔقΒسϤلا ΔقفاϮϤلا جΫϮϤϧ 
،ϦρاϮϤϟا ϱΰϳΰع 
ΔϴϧΎϨΒϠϟا ΔعϣΎΠϟا ϲف ΔعΎϨϤϟا ϢϠع ήΒΘΨϤϟ عΑΎΘϟا ثحΒϟا قϳήف ΎϴϟΎح ϡϮϘϳ  ،ϙέϮϳϮϴϧ ΔعϣΎΟ عϣ ϥϭΎعΘϟΎΑ ، ϰϟ· فΪϬΗ ΔγاέΪΑ 
 ϯΪϟ ΔعΎϨϤϟا ϯϮΘδϣ ΪϳΪحΗ ϦϴϴϧΎϨΒϠϟا ϩΎΠΗ" ϰϤح αϭήϴفϞϴϨϟا Ώήغ "ϞϘΘϨΗ ϯήخأ ΕΎγϭήϴفϭ ϥΎδϧإا ϰϟ· ΓΆΑϮϤϟا έϮϴطϟا Ϧϣ 
νϮعΒϟا ΕΎغΪϟ قϳήρ Ϧع.  ϱΩΆΗ Ύϣ ًاέΩΎϧ ϰϤحΑ ΐΒδΘΗ Ϊق ًΎϧΎϴحأϭ ،νέاϮع ϥϭΩ Ϧϣ αϭήϴفϟا اάϬΑ ΕΎΑΎصإا ϥϮϜΗ Ύϣ ًΎΒϟΎغ
ΕϮϤϟاϭ ϲΒμعϟا ίΎϬΠϟا ΔΑΎصا ϰϟ·. 
ΔΒδϧ ΪϳΪحΗ Ϯه ΔγاέΪϟا ϩάϬϟ ϲδϴئήϟا فΪϬϟا  ϥΎϜδϟا νήعΗΎϬϟ ΓΩΎπϤϟا ϡΎδΟأا Ϧع ثحΒϟΎΑ αϭήϴفϟا اάϬϟ  ΕΎϨϴع ϲف
ϥΎϜδϟا Ϧϣ άخΆΗ ΔϴϠμϣ . ϞΟأ Ϧϣ ΔΒγΎϨϣ ΔϴئΎقϭ ΔγΎϴγ Ϣγήϟ ΔμΘΨϤϟا Δϴحμϟا ΕΎطϠδϟا فήμΘΑ ΔγاέΪϟا ϩάه ΞئΎΘϧ عضϮΗ
ΔϴϠΒϘΘδϤϟا ΕΎΑΎصاا Ϧϣ Ϊحϟا. 
يلاتلا ىجήي ،ΔساέΪلا هάه يف ΔكέاشϤلا Δيغب: 
  -ΔϴئΎΑϮϟا ΔϴئΎμحاا ΕΎγاέΪϟا ءاήΟا ϞΟأ Ϧϣ ΔϘفήϤϟا ΓέΎϤΘγاا ءϞϣ .
  - Ώ عήΒΘϟا5ϡΪϟا Ϧϣ Ϟϣ . 
 
ϥأب اϤلع مكتطاحإ دϮϧ: 
  -ΔϴϧΎΠϣ ϲه ΔϳήΒΨϤϟا ΕΎصϮحفϟاϭ ΏέΎΠΘϟا .ΔϴΜحΑ ΔحϨϤΑ ΎϬΗΎϘفϧ ΔϴطغΗ ϢΘϳ .
  -ΐϠطϟا ΪϨع عήΒΘϤϠϟ ϡΪϘΗϭ ،Δϳήγ ϰϘΒΗ ΕاέΎΒΘخاا ΞئΎΘϧ .
  -ΔγاέΪϟا ϩάه νήغϟ ςϘف ϡΪΨΘδΘγ ϡΪϟا ΕΎϨϴع. 
 
مكتكέاشم مكل ήكشϧϭ! 
 
ΔساέΪلا هάه يف ΔكέاشϤلا Δيήحب لΒقأϭ ،هاعأ ΓέϮكάϤلا ΕامϮلعϤلا ΖϤϬفϭ Εأήق Ϊقل. 
خيέاتلا: 
ΓήϬشلاϭ مساا: 
عيقϮتلا: 
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Appendix B: Questionnaire in Arabic 
ΓέاϤتساا 
ΓέΎϤΘγاا Ϣقέ:      ................................ϥΎϜϤϟا     ................................. :خϳέΎΘϟا................................: 
ΓήϬشϟاϭ Ϣγاا................................. : 
1. βϨΠϟا   :  ฀      ήϛΫ ฀   ϰΜϧأ 
2. ΓΩاϮϟا ΔϨγ                             ................................. :ΓΩاϮϟا ϥΎϜϣ................................. : 
3. ϞϤعϟا عϮϧ:.................................     ฀                 ϞϤعϳ ا      
4.  قϠغϣ ϥΎϜϣ ϲف ϞϤعΗ Ϟه(ϰϨΒϣ ϞخاΩ) ؟ϲΟέΎخ ϭأ  .................................   
 ฀ϲϠخاΩ :ϞϤعϟا ϡاϭΩ ϝاخ ًΎΟέΎخ ًΎϴϣϮϳ ΔعΎγ Ϧϣ Ϟقأ 
 ฀ϲΟέΎخ :ϞϤعϟا ϡاϭΩ ϝاخ ًΎΟέΎخ ًΎϴϣϮϳ ΔعΎγ Ϧϣ ήΜϛأ 
5. ΔϴϟΎحϟا ΔϣΎقإا ϥΎϜϣ................................. : 
6. ϲϧΎΜϟا ϦϜδϟا ϥΎϜϣ (ΪΟϭ ϥ·)   ................................. : 
7. ΖΒصأ Ϟه؟ϞصΎفϤϟاϭ Εاπعϟا ϲف ϡاآϭ ،ΩΎح عاΪμΑ ΔطΒΗήϣ ΓΪϳΪش ϰϤحΑ ،ΔϴضΎϤϟا ΔثاΜϟا ΕاϮϨδϟا ϝاخ ، 
       ฀        Ϣعϧ   ฀  اϛ    
 ϝΎح ϲف،Ϣعϧ 
- ϰΘϣ؟  ฀      ΔϴϟΎحϟا ΔϨδϟا   ฀           ΔϴضΎϤϟا ΔϨδϟا   ฀                ΔϴضΎϤϟا ΔϨδϟا ϞΒق Ύϣ  
- ؟ϰϤحϟا ΐΒγ ϥΎϛ Ύϣ 
   ฀  ΔϳήΒΨϣ ΕΎصϮحف Δϳأ ϢΘΗ Ϣϟ  ฀         ΐΒδϤϟا ϞϣΎعϟا Ϧع فشϜΗ Ϣϟ ΖϳήΟا ϲΘϟا ϞϴϟΎحΘϟا  
    ฀Ϯهϭ ΐΒδϤϟا ϞϣΎعϟا ΪϳΪحΗ ϢΗ ................................. :
8. ؟ϢϴϘΗ ثϴح νϮعΒϟا ΕΎغΪϠϟ νήعΘΗ Ϟه ................................. 
9.   ؟ϚϟΰϨϣ άفاϮϧ ϝϮح νϮعΒϠϟ عϧΎϣ ϚΒش ΪΟϮϳ Ϟه      ฀        Ϣعϧ   ฀  اϛ    
10.  ϚϨϜγ ϥΎϜϣ Ϧϣ ΏήϘϟΎΑ ΔΘΑΎث ϩΎϴϣ έΪμϣ ϭأ عϘϨΘδϣ ϱأ ΪΟϮϳ Ϟه(100ϡ )؟ ฀              Ϣعϧ   ฀  اϛ    
11.  ϚϨϜγ ϥΎϜϣ Ϧϣ ΏήϘϟΎΑ ϡΎϤح ΖϴΑ ϭأ ΝΎΟΩ Ϧق ϱأ ΪΟϮϳ Ϟه(100ϡ )؟ ฀              Ϣعϧ   ฀  اϛ    
12.     ؟ϦϠϨΒϟ ΝέΎخ ΖϤقأ Ϟه฀         Ϣعϧ    ฀ ؟Ϧϳأ        اϛ   ..........................    ؟ΔϨγ .......................... 
 ΔϴفΎضا ΕΎϣϮϠعϣ...........................................................................................................................  
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Appendix C: Informed Consent Form in English 
Dear Participant, 
The research team of the Laboratory of Immunology at the Lebanese University, in 
collaboration with the University of New York, is conducting a study to evaluate the immune 
status of Lebanese population against West Nile Virus. This virus is transmitted from infected 
birds to humans by the bite of a mosquito. In most of the cases, the infection remains 
asymptomatic. Otherwise, it causes acute febrile illness, and rarely leads to encephalitis, causing 
long term disability or even death. 
The main objective of this study is to search for the presence of specific antibodies in human 
which is indicative of previous exposure to the virus. The obtained results will be submitted to 
the Lebanese Health authorities to take necessary preventive measures. 
In order to participate in this study, you are kindly requested to: 
- fill out the attached questionnaire that will be used for statistical and epidemiological 
analysis. 
- donate 5 ml of blood for laboratory analysis. 
We would like to inform you that: 
- The laboratory tests are free of charge.  Their costs will be covered by a research grant. 
- All results and provided personal information will remain secret and be treated in 
complete anonymity. The blood analysis results of each donor can be provided to him 
upon his request. 
- The blood sera will be solely used for the purpose of this current study. 
Thank you for your participation 
I have read and understood the above mentioned information. I freely accept to 
participate to this study.   
Date: 
Name: 
Signature:  
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Appendix D: Questionnaire in English 
 
Questionnaire numberμ ………….       Placeμ ………….       Dateμ …………. 
Name: ................................. 
1. Gender:     ฀ Male                   ฀ Female  
2. Year of Birth: .................................                        Place of Birth: ................................. 
3. What is your work type? .................................     ฀  Don’t work   
4. Do you work inside a building or outside? ................................. 
฀   Inside: less than one hour outside during work time 
฀   Outside: more than one hour outside during work time 
5. Place of current residence: ................................. 
6. Place of other residence (if present): ................................. 
7. Have you suffered, in the past three years, from a febrile illness associated with severe 
headache, and important muscle and joint pains?   ฀  Yes        ฀  No  
 If yes:  - When?     ฀  this year     ฀  last year     ฀  years before 
                        - What was the reason? ฀  the causative agent was: ................................. 
  ฀  no performed tests ฀  performed tests didn’t reveal the causative agent  
8. Do you get bitten by mosquitoes at your residence? ................................. 
9. Do your house windows have nets for mosquitoes?   ฀  Yes        ฀  No 
10. Is there any lake or stagnant water near your place of residence (100m)?   ฀  Yes        ฀  No 
11. Is there any chicken coop or pigeon house (loft or dovecote) near your place of residence 
(100m)?   ฀  Yes        ฀  No 
12. Did you live outside Lebanon (abroad)?   ฀  Yes          ฀  No 
Where? .................................                 When? ................................. 
Additional information .............................................................................................................. 
143 
 
Appendix E: Coating buffer, 10X PBS Buffer and 10X TBE Buffer 
Preparations 
 
1. Coating buffer (pH 9.6) 
Combine 0.3975g of Na2CO3 (0.015M) (Uni-Chem, MW 105.99), 0.7325g of NaHCO3 
(0.035M) (Sigma Aldrich, MW 84.01) and 250mL ddH2O. Stir until dissolved, check for correct 
pH and adjusted it then store the solution at 4°C. 
 
2. Preparation of 1L of 10X TBE Buffer 
The following salts were dissolved in 800ml deionized water: 108g of Tris Base (Sigma 
Aldrich) and 55g of Boric Acid (Amresco). Then 40ml of prepared 0.5M EDTA (Scharlou) 
(pH=8) was added to the mixture and the volume was completed to 1L with deionized water. 
 
3. Preparation of 5L of 10X PBS Buffer 
The following salts were dissolved and stirred in 5L deionized water until all the salts were 
well dissolved: 340g of NaCl (Sigma Aldrich), 139.5g of Na2HPO4, 7H2O (Sigma Aldrich) and 
21.5g of KH2PO4 (Sigma Aldrich) (pH of 10X PBS between 7 and 7.4). After dilution, 1× PBS 
was obtained with a pH between 6.8 and 7. 
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Appendix F: ELISA Plate Plan 
 
 Neg Ag WNV Ag Neg Ag WNV Ag Neg Ag WNV Ag Neg Ag WNV Ag 
 1 2 3 4 5 6 7 8 9 10 11 12 
A C + (1) S1 S9 S17 
B C + (2) S2 S10 S18 
C C + (3) S3 S11 S19 
D C - (1) S4 S12 S20 
E C - (2) S5 S13 S21 
F C - (3) S6 S14 S22 
G Sec. Ant. S7 S15 S23 
H Blank S8 S16 S24 
C +: positive control, C -: control negative, Sec. Ant.: Secondary Antibody, S1: serum 1, 
…, S24μ serum 24.  
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Appendix G: Pools details 
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